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ABSTRACT 
Appendicitis affects 7-9% of Americans and is the most common diagnosis requiring 
hospitalization of both children and adults. Several etiologies of appendicitis have been 
hypothesized, but definitive mechanisms remain elusive – a critical review of the literature does 
not support a primary role of fecaliths or lymphoid hyperplasia, as is commonly believed.  It is 
known that appendicitis has heritable components, and so we collaborated with 23andMe Inc., a 
personal genomics company, to identify genetic determinants of susceptibility to acute 
appendicitis. 23andMe performed a genome-wide association study (GWAS) of 18,773 
appendectomy cases and 114,907 controls, and identified one locus with genome-wide 
significance. In addition, the GWAS identified eight highly significant SNPs that did not reach 
genome-wide significance. Most of the SNPs identified using this analysis fell outside of protein-
coding genes, thus bioinformatic analysis using RegulomeDB was done to interrogate the SNPs’ 
putative regulatory capacity of nearby or distant genes, or proteins.  
This analysis identified 921 targets of putative regulatory elements in the same LD 
blocks as the four of nine lead SNPs identified in the GWAS and chosen for follow-up study. 
Of these, 299 targets were unique when targets from all four genomic regions were 
combined. These targets were organized according to the distance of their putatively  
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regulatory SNP from the given lead SNP, and based on overlap of elements’ targets within 
one region with targets of elements within the rest of the genomic regions. Ultimately, the 
following list of 17 proteins was generated for priority in further studies: CEBPB, CTCF, 
EP300, EVI-1, FOS, FOXJ3, FOXP1, GATA1, HNF4A, JUN, MYC, NFKB, PPARG, 
RAD21, SPI1, STAT1, and STAT3. This list includes several proteins that directly interact 
with, or influence the expression of very specific inflammatory markers known to be strongly 
associated with appendicitis, including IL-8, IL-1B, and IL-6. This outcome supports the 
utility of RegulomeDB in the interpretation of GWAS-generated non-coding variants.  
This compiled resource and the ongoing parallel studies born of the appendectomy 
GWAS may help to elucidate the pathogenesis of acute appendicitis, thereby providing 
opportunities to improve the diagnosis, treatment, and prevention of this extremely common 
disease. The public health significance of appendicitis and its genetics are addressed, and a 
theoretical public health program that integrates the multiple factors involved in appendicitis 
etiology is proposed. 
v 
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1.0  INTRODUCTION 
Appendicitis is a common, complex disease of unknown etiology. In this study, the genetic 
component of the disease was investigated through a multidisciplinary collaboration between a 
public university and a private company. The basis for the study was citizen science - the 
sizeable genetic data set analyzed was gathered from consenting research participants who had 
purchased a direct-to-consumer genetic test and had answered medical history questions.  
In this work, a genome-wide association study (GWAS) of appendectomy identified one 
single nucleotide polymorphism (SNP) with genome-wide significance, and eight SNPs that 
were highly significant, but did not reach this threshold. As expected, most of these nine lead 
SNPs fell outside of protein-coding genes, and thus their role in appendicitis etiology was less 
easily understood than if they had clearly altered the structure or function of known genes. It is 
possible that lead SNPs that fall within non-coding regions are instead involved in the regulation 
of distant or nearby genes that contribute to disease pathogenesis or are protective of it by this 
less direct mechanism. If these identified non-coding SNPs represent true associations, it is 
imperative to use available resources to interpret their significance for the disease. One such 
novel resource is RegulomeDB1 – a database of putative regulatory variants, the genetic elements 
by which the variants are thought to exert their effects, and the elements’ target genes or 
proteins. RegulomeDB has previously been used to successfully interrogate GWAS associations 
falling in protein coding and non-coding regions2. The broad aim of this study was to use this 
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database to help interpret the role of the non-coding variants identified in the appendectomy 
GWAS. 
The first specific aim was to prioritize which SNPs associated with appendectomy to 
examine in this follow-up study. A second aim was to extract from RegulomeDB the putative 
regulatory variants from the vicinity of the prioritized lead SNPs, and to organize them based on 
the level of evidence supporting their capacity to be regulatory. A third aim was to further 
prioritize these SNPs, the regulatory elements by which they are thought to exert their effects, 
and the gene or protein targets of these elements for follow-up study. A final aim was to develop 
hypotheses as to the putative role of some of the targets identified in appendicitis etiology based 
on existing literature.  
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2.0  BACKGROUND 
2.1 APPENDICITIS AND ITS ETIOLOGY 
Acute appendicitis is the inflammation of the vermiform appendix, a tubular organ that protrudes 
at the base of the cecum. It frequently presents with central abdominal pain, followed by 
vomiting and migration of the pain to the right-inferior part of the abdomen3. The initial pain is 
colicky in nature for the first 24 hours, and transforms to a more constant and severe pain after 
migration. Loss of appetite, constipation, and nausea co-occur often4. 
Acute appendicitis is considered a common disease; it affects 9.38 per 10,000 people in 
the United States every year5. It is the fifth most common indication for non-neonatal pediatric 
hospitalization, and is the second most common inpatient pediatric procedure6. Incidence peaks 
among children aged 10-14; it is more common in males than females, and more common among 
whites and Hispanics, relative to other races. The lifetime risk of developing appendicitis is 9%7.  
The appendix is commonly thought to be evolutionarily vestigial in humans, left over 
from a time when our ancestors were herbivorous, and the organ was longer and served as a 
reservoir of cellulose-digesting bacteria8. It has also been proposed to be an immune organ due to 
the presence of significant gut-associated lymphoid tissue (GALT) within it9. More recent 
research suggests that the appendix may play a key role in the maintenance of commensal 
intestinal bacteria that, in turn, play a large role in the human immune system10,11. Findings that 
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support this assertion include the appendix’s unique position in the intestinal tract, its shape, the 
abundance of mucus production within it, and that lymph tissue supports mutualistic biofilms in 
the gut12.  
Interestingly, there is increasing evidence that appendicitis results from a complex 
interaction between host genotype and the microbial environment of the intestines (the gut 
microbiome). Expression and protein studies of inflamed and non-inflamed appendices have 
found altered mRNA expression and differences in protein levels within the enterocytes, the cells 
lining the intestines. DMBT1, a secreted glycoprotein thought to play a role in enterocyte 
differentiation and bacterial defense, was found to have five-fold increased expression and 
corresponding increases in protein level in inflamed appendices13. In addition, several studies 
have shown that appendicitis is associated with the local growth of the gram negative pathogen, 
Fusobacterium nucleatum14-16. In a series of 52 inflamed appendices from several countries, 62% 
had invasion of this pathogen15. This organism is not typically present at significant levels in the 
GI tract; it is normally found in the oral cavity. It is a central player in the etiology of periodontal 
disease, and its translocation is frequently found in extra-oral infections, including the amniotic 
fluid of pre-term infants17.  The bacterial risk factors for appendicitis may be set in place from a 
young age. In one study, children with appendicitis were found to have been breastfed for 74% 
of the duration of the time of children without appendicitis18; breastfeeding is known to modify 
infant immune response to microbial agents. 
The leading theory as to the cause of appendicitis states that the organ’s inflammation 
results from an obstructive process of the lumen – the tubular cavity of the appendix. The 
obstruction is thought to be due to fecaliths (hard masses of feces) or lymphoid hyperplasia19. 
However, several studies have not supported fecaliths nor lymphoid hyperplasia as a primary 
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cause of obstruction in a majority of cases of appendicitis20-23. Instead, they suggest that local 
inflammation precedes the luminal obstruction24. In addition, dietary intake of fiber is considered 
to be a significant factor in appendicitis etiology; lower intake of all fiber fractions is frequently 
found among appendicitis patients relative to controls25.  Finally, the “hygiene hypothesis” has 
been proposed as part of the explanation for appendicitis etiology, namely that improved 
sanitation practices in industrialized countries have resulted in individuals having less exposure 
to microbes. This is thought to result in corresponding “over-reactions” to later infections that 
then trigger appendicitis26. Barker et al, proponents of the hygiene hypothesis, argued against a 
dietary cause of appendicitis by citing the example of the blacks in South Africa who – in spite 
of eating a Westernized, low-fiber diet – had low rates of appendicitis27.  
An alternative proposed etiology of appendicitis is that it is precipitated by Type 1 
Hypersensitivity, a type of allergic response, and that infection is a later consequence28. A 
finding that supports this theory is that the levels of eosinophils – pro-inflammatory leukocytes 
equipped to participate in gastrointestinal tract inflammation – have been found to be 
significantly elevated in the serum of individuals with appendicitis, relative to controls29. 
Eosinophils have also been found to be significantly elevated within the muscularis of the 
appendix (the smooth muscle surrounding the appendix) in acute appendicitis along with features 
of mast cell degranulation, relative to control appendices. This was suggested to be an early 
finding in the pathogenesis of the disease – not a consequence of subacute or chronic 
inflammation28. Eosinophils have also been found to be elevated in the irritable bowel disease 
ulcerative colitis, but their definitive role in disease remains elusive30. However, a subsequent 
study of inflammatory gene expression of inflamed appendices found a very focused 
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inflammatory response and concluded that appendicitis was unlikely to be due to a Type 1 or 
Type 2 immune response31.  
Finally, Ballester et al found that individuals who had had a tonsillectomy had a 2.57-fold 
increased odds for subsequent appendectomy32. The authors proposed two possible explanations. 
First, tonsillectomy could produce a deficiency in lymphoid tissue which induces the GALT 
tissue within the appendix to overcompensate in response to incoming pathogens and become 
overly inflamed. Alternatively, higher rates of tonsillectomy and appendectomy could both be a 
result of genetic predisposition to a hyperactive immune response and hypertrophy.  
Although the first official diagnosis of appendicitis and subsequent appendectomy were 
performed in 188033, a specific etiology of acute appendicitis has not been firmly established to 
this day. 
2.2 APPENDICITIS DIAGNOSIS AND ITS TREATMENT 
The diagnosis of acute appendicitis depends primarily on clinical findings. There is no diagnostic 
test for appendicitis, but urinalysis and serum screens can help rule out some two dozen 
differential diagnoses. The Alvarado score is a clinical scoring system occasionally used to aid in 
diagnosis, and depends on the patient’s medical history, physical examination, and blood lab 
tests4. The imaging techniques ultrasonography and computed tomography (CT) scanning are 
also used to aid in diagnosis, however a longitudinal study of these techniques did not find that 
their introduction lowered false positive diagnoses resulting in unnecessary appendectomies 
(“negative appendectomies”)34. Other studies have shown more favorable results for CT 
scanning. However, with CT scanning there is concern regarding unnecessary exposure of long 
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duration to the risks of ionizing radiation4.  Unfortunately, these technologies are not available at 
all hospitals, and when they are, making arrangements for their use can further delay diagnosis. 
Thus, there remains a need for a rapid, non-invasive diagnostic test for the condition. 
The treatment of choice for appendicitis is the surgical removal of the appendix – 
appendectomy – within the first 24 hours of the onset of symptoms35. Delays past this time 
window are associated with an increased risk of perforation of the appendix, and spillage of the 
contents of the appendix into the abdominal cavity. This results in a worse prognosis and a 
longer hospital stay. If surgery is delayed more than 36 hours after the onset of symptoms, the 
rate of perforation can be as high as 36%36. Broad spectrum antibiotics are typically administered 
to help prevent postoperative wound infections and intra-abdominal abscesses.  
2.3 GENETICS OF APPENDICITIS 
Epidemiological and genetic studies of acute appendicitis suggest that it is a complex, 
multifactorial disease with environmental, bacterial, and several genetic components. Currently, 
there is no evidence for a single gene cause of appendicitis37. However, the existence of a rare 
single genetic cause in a small proportion of cases can’t be ruled out – there have been reports of 
families with up to 39 individuals affected, some of whom shared anatomic defects of the 
organ38. Nevertheless, the vast majority of cases are presumed to be due to multifactorial causes, 
and mathematical models predict that the genetic component is polygenic37. 
Acute appendicitis demonstrates clear heritability in family and twin studies37,39. Genetics 
account for 30-56% percent of the risk of appendicitis; and environmental effects account for the 
remainder of the risk37,40. Other studies have found the heritability to be 27% and the effect of 
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shared familial environment to be 16%41. A positive family history of acute appendicitis 
increases the relative risk of appendicitis up to 10-fold9. A number of association studies have 
been done between polymorphisms in genes involved in innate immunity and the inflammatory 
response, and the occurrence or severity of appendicitis. C-allele carriage at −174 in the IL-6 
gene (rs1800795) is associated with severe appendicitis, and with lower plasma and peritoneal 
fluid IL-6 protein levels42. However, this study examined a small number of SNPs, and the 
sample size was limited. 
2.4 GENE EXPRESSION IN APPENDICITIS 
It is known that appendicitis is correlated with differential expression of a core set of genes 
involved in the inflammatory response, with similar genes being activated in cases of mild and 
severe appendicitis. This set of genes is highly enriched in mediators of the innate inflammatory 
response and is specific to acute appendicitis (as distinct from other inflammatory diseases of the 
bowel)31. The specific gene expression profile of acute appendicitis lends support to a 
bacterially-mediated etiology of the disease. In particular, one cytokine gene differentially 
expressed in acute appendicitis (IL-1β) is strongly induced by bacterial products such as 
lipopolysaccharide (LPS, a part of the outer membrane of gram-negative bacteria) 31. In addition, 
the study also found a significant upregulation of the neutrophil chemoattractant interleukin-8 
(IL-8) in proportion with the extent of inflammation in the appendix31. IL-8 is induced through 
several pathways and in response to LPS, TNF, IL-1, and through cell-mediated immunity. It has 
also been found to have elevated expression in inflammatory bowel diseases43-45.  
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IL-8 upregulation in peritoneal fluid of individuals with appendicitis has been reported 
previously46,47. Interestingly, in an assay screening various pathogenic bacteria isolated from 
peritoneal exudate fluids of patients with appendicitis, Fusobacterium necrophorum was capable 
of induction of IL-8 from cultured human mesothelial cells to levels found in-vivo in peritoneal 
fluids of patients with appendicitis. This bacterium when heat-killed, and its supernatant also 
induced elevated IL-847. 
Serum levels of various interleukins have been studied as possible diagnostic markers. In 
one study, IL-6, but not IL-8 expression has been found to be elevated in the serum of patients 
with appendicitis48. In another, both pre-operative IL-6 and IL-8 were found to be higher in 
patients with perforated as compared with non-perforated appendicitis49.  
2.5 THE GENETICS OF COMMON COMPLEX DISEASE 
Common complex diseases are ones that do not display a clearly recognized inheritance pattern 
and typically have several factors that contribute to their etiology like environmental exposures 
such as diet, infectious disease, toxins, and internal factors like aging.  
There exist several theories for the role genetics plays in complex diseases that are 
common in the general population. The common disease, common variant (CD/CV) hypothesis 
states that the genetic contribution to diseases common in the general population - the heritability 
- is moderated by a combination of several common genetic variants. It follows that due to the 
high frequency of these variants, their individual contributions to the overall disease risk – their 
effect sizes - are small.  
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Common risk alleles are thought to be common because their negative effect on relative 
fitness is small, and thus selection pressure against them is correspondingly small. It is likely that 
these risk alleles became common many thousands of years ago, in an environment that differed 
significantly from the one that exists today. Indeed, the prevalence of appendicitis is greater in 
industrialized nations than in developing ones, and explanations of this phenomenon have been 
in line with the evolutionary mismatch hypothesis (EMH)26,27,50. The EMH states that disease 
common in the general population is due to a mismatch between the environment that humans 
had evolved in, and the pressures of the modern lifestyle; certain evolved traits may be 
maladaptive and lead to disease in the context of modern civilization.  
There are many additional factors that could have produced a random increase in risk 
alleles. For example, it is also possible that a variant that increases the risk for a certain disease 
is, in fact, protective against other ailments. Alternative explanations for the genetics of common 
complex disease include the common disease, rare variant (CD/RV) hypothesis, which states that 
common disease is caused by multiple rare variants with larger effect sizes. The determination of 
which of these hypotheses applies more to appendicitis would greatly influence the clinical 
applications of the genetic variants identified – for example, therapeutic and prognostic assays 
would be greatly simplified if only a handful of variants were known to influence disease risk51. 
The genome wide association study (GWAS) is a genetic technique for identifying 
common genetic variants that are associated with a given disease in a group of individuals. A 
GWAS strives to take a broad, un-biased “discovery” approach to determining the genetic 
determinants of disease by querying thousands of SNPs across the genome at once. This can be 
contrasted with a more limited approach of focusing research on a select few genes that are 
predicted to be most important to disease etiology given their function. The strength of the 
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GWAS study is in numbers: by comparing large sample sizes of individuals with and without 
disease (typically in the thousands), it is able to identify the genetic differences of small effect 
size associated with the particular disease. Given the CD/CV hypothesis, this approach is 
particularly powerful for elucidating the more “subtle” genetics of common complex disease like 
acute appendicitis.  
The output data of a GWAS study are SNPs (single nucleotide polymorphisms) or other 
genetic variants that are associated with increased or decreased risk for the condition. However, 
identifying SNPs in a GWAS is only a preliminary step in identifying risk loci for a common 
disease such as appendicitis. This is so because SNPs identified through GWASs don’t 
necessarily “cause” disease, but are markers for other genetic factors that may truly modify risk -
- often, SNPs have been inherited within sections of DNA for generations (termed linkage 
disequilibrium), and thus their association with a disease is in reality a surrogate for the true risk 
factor in their vicinity. An ideal situation for the interpretation of GWAS results is when the 
associated SNP is causal – for example, it is located inside a gene which makes the said gene 
function sub-optimally and results in an increased likelihood of disease. However, this scenario 
is rare. Given that the vast majority of our DNA (~97%) is not made up of protein-coding genes, 
it is not surprising that most SNPs identified in GWASs fall in intergenic regions. These regions 
likely have regulatory activity of nearby or distant sites2, thus to truly understand their 
significance, it is necessary to examine the identified polymorphisms’ regulatory potential.   
The aim of the present study was to interpret the significance of the SNPs identified in 
the GWAS of appendectomy conducted by the company 23andMe. Specifically, the goal was to 
use RegulomeDB to identify the variants with putative regulatory potential within the regions in 
the same LD block as the lead SNPs of the GWAS. Once identified, a list of the elements 
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putatively regulated by these variants would be compiled, and the regulatory targets would be 
organized and prioritized to enable more focused follow-up study.  
The variants identified as being potentially regulatory through this study were screened 
for their regulatory effects on three types of elements: eQTLs, motifs, and proteins (transcription 
factors). Expression quantitative trait loci (eQTLs) are typically polymorphisms that significantly 
influence the expression of near or distant genes. Protein binding sites are genetic sequences that 
have an affinity for certain proteins to bind, typically with the aim of inducing or repressing 
transcription. The strength of this affinity can be modified by regulatory polymorphisms within it 
or at more distant locations. Motifs are sequences of several nucleotides in length that can be 
binding sites for transcription factors, which, in turn, regulate expression of nearby genes. Of 
note regarding nomenclature: the “targets” of motifs listed in this study do not refer to these 
nearby genes – instead, motif “targets” identified using RegulomeDB refer to the transcription 
factors whose binding is affected by the putative regulatory variant within the motifs. 
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3.0  SIGNIFICANCE 
3.1 ACUTE APPENDICITIS AND PUBLIC HEALTH 
Acute appendicitis affects 9% of females and 7% of males in the United States19.  More than 
300,000 appendectomies are performed annually52.  Mortality due to non-perforated appendicitis 
is 0.8 in 1,000, but 5.1 in 1,000 for perforated appendicitis4. Complications can include wound 
infection (up to 20%, if appendix is perforated), and intra-abdominal or pelvic abscesses. 
Recovery time can range from 10 to 28 days in adults, depending on complications and 
individual risk factors, however hospital stays are between 2 and 5 days long, on average53. 
Disparities exist in time to diagnosis, and those presenting later are at a higher risk of 
having perforated appendicitis. This is especially true for young children and elderly individuals. 
Perforation rates at presentation to the hospital in young children can be as high as 97%4, in 
comparison with an average rate of approximately 30%53. Individuals with schizophrenia are 
also at increased risk of having perforated appendicitis, largely due to delays in time to 
diagnosis54. In addition, the following other groups have higher rates of perforation and longer 
time to presentation to the healthcare system: African Americans, individuals covered by 
Medicaid, and those who are uninsured53. 
An appendectomy for non-perforated appendicitis has an average cost of $7,800. An 
average appendectomy for perforated appendicitis costs 50% more - $12,80053. Hospital charges 
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for appendectomies can range from $1,529 to $182,955, with a median price of $33,000 for 
uncomplicated appendicitis55.  
Certain populations are at greater risk of complications due to appendicitis. Appendicitis 
during pregnancy can be fatal in 4% of mothers in cases of perforated appendicitis; 1 in 1,000 
pregnant women are affected by acute appendicitis56. The fetus is also at 20-35% risk of death in 
cases of perforated appendicitis57. The diagnosis of appendicitis is particularly complicated 
during pregnancy because the fetus’ as well as the mother’s wellbeing must be taken into 
account when weighing the risks and benefits of the various diagnostic procedures. In these 
situations, laparoscopic diagnosis of appendicitis can result in a negative appendectomy in a 
staggering 40% of cases, and radiation exposure to the fetus and the mother during imaging must 
be taken into account56.  
Interestingly, appendectomy can relieve or prevent other gastrointestinal conditions. 
Appendectomy significantly improves the symptoms of the large majority (90%) of patients with 
ulcerative proctitis, a subtype of ulcerative colitis. In 40% of these patients, the surgery leads to 
complete remission of symptoms58. Furthermore, a meta-analysis has shown that appendectomy 
reduces the risk of developing ulcerative colitis by 67%59.   
Although there have been great improvements in the diagnosis of appendicitis – in 
previous decades the negative appendectomy rate exceeded 20% of all appendectomies60 – 
approximately every one in twelve appendectomies is unnecessary today61. Women are more 
than twice as likely as men to have a negative appendectomy61. Negatives appendectomies are 
not without medical consequences: they are fatal in approximately 1% of cases61.  
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4.0  METHODS 
4.1 MULTIDISCIPLINARY COLLABORATION 
The University of Pittsburgh team submitted a research proposal to receive access to de-
identified aggregate analysis from 23andMe database of genotype and phenotypic data from 
research participants. The data received from 23andMe included the results of the GWAS 
conducted by 23andMe on the appendectomy phenotype.  Lead SNPs identified through the 
GWAS study were subsequently annotated by the University of Pittsburgh group using 
RegulomeDB and organized for follow-up study. The University of Pittsburgh team’s 
collaboration with 23andMe, the team’s access to the GWAS data and supporting documents 
from 23andMe’s database, and the subsequent annotation of the GWAS data for this project were 
approved by the Institutional Review Board (IRB) of the University of Pittsburgh (Appendix B). 
4.2 GWAS STUDY DESIGN 
A genome-wide association study was conducted by 23andMe using the appendectomy 
phenotype on data from 23andMe research participants, who provided informed consent to 
participate in research under the 23andMe research protocol approved by the external AAHRPP-
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accredited IRB, Ethical & Independent Review Services (E&I Review). This cohort of research 
subjects has been described previously62-65.   
4.3 STATISTICAL ADJUSTMENT  
Logistic regression was performed assuming an additive model for allelic effects using the 
model: appendectomy ~ age + sex + pc.0 + pc.1 + pc.2 + pc.3 + pc.4 + genotype. The age 
variable refers to age at the time of genotyping, not age at appendectomy. Covariates for age, 
gender, and the top five principal components of ancestry were included to account for residual 
population structure. The genomic control procedure was used to compensate for variance 
inflation due to residual population stratification that had not been effectively controlled for 
through use of principal components in the regression models. The results were adjusted for a 
calculated genomic control inflation factor of 1.034.  
4.4 GENOTYPING AND QUALITY CONTROL MEASURES 
The GWAS included research participants’ genetic data generated through the use of the 
23andMe® Personal Genome Service (PGS), a saliva-based direct-to-consumer genotyping 
service. 23andMe has used four genotyping platforms since it released the PGS in 2007, and data 
from these four platform were included in the GWAS - The V1 and V2 platforms were variants 
of the Illumina HumanHap550 BeadChip with additional custom SNPs curated by the 23andMe 
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research team. The V3 platform is a variant of the Illumina OmniExpress+ BeadChip, also with 
custom SNPs. The current V4 platform is a custom array.  
The GWAS also included imputed SNPs computed against the March 2012 “v3” release 
of 1000 Genomes haplotypes (phase 1 variants list)66. Data from each genotyping platform was 
phased and imputed separately. Beagle67 (version 3.3.1) was used to phase batches of 8000-9000 
individuals across chromosomal segments of 10,000 or fewer genotyped SNPs, with overlaps of 
200 SNPs. The following SNPs were excluded: those with call rate < 95%, with Hardy-
Weinberg equilibrium P<10−20, or with large allele frequency discrepancies compared to 
European 1000 Genomes reference data. The phased segments were imputed against 1000 
Genomes haplotypes of all ethnicities (excluding monomorphic and singleton sites); a high-
performance version of Minimac68 was used, with  5 rounds and 200 states for parameter 
estimation. 
Males and females were phased together in segments for the non-pseudoautosomal region 
of the X chromosome. Males were treated as already phased, while the pseudoautosomal regions 
were phased separately. Next, males and females were imputed together using minimac, as was 
done with the autosomes, treating males as homozygous pseudo-diploids for the non-
pseudoautosomal region. 
For tests using imputed data, the imputed dosages were used, rather than the best-guess 
genotypes. The association test P value reported was computed using a likelihood ratio test. 
Results for the X chromosome were computed similarly – men were coded as if they were 
homozygous diploid for the observed allele. 
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4.5 POPULATION DESCRIPTION 
The GWAS was restricted to research participants who had more than 97% European ancestry; 
ancestry was determined through comparison with the three HapMap2 populations69. Close 
relatives were excluded using a segmental identity-by-descent (IBD) estimation algorithm70. 
Close relatives were defined as those who share more than 700 cM IBD - either one or both 
genomic segments IBD - which corresponds to the amount of expected sharing between first 
cousins in an outbred population (approximately 20% of genetic information). 
4.6 APPENDECTOMY PHENOTYPE DETERMINATION 
The appendectomy phenotype for the GWAS was ascertained based on research participants’ 
voluntary answers to online health history questionnaires deployed in the 23andMe website.  The 
appendectomy cases were identified from two questions in two separate questionnaires: “Have 
you ever had your appendix removed?”; answer choices consisted of “yes,” “no,” and “I’m not 
sure.” The second question was “Have you ever had any of the following other surgeries?”; 
answer choices to the “appendectomy” selection included “yes,” “no,” and “I don’t know.” Cases 
answered in the affirmative to either question, while controls answered in the negative. 
Individuals who responded with discordant results to the two questions were excluded from the 
study. 
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4.7 ASSOCIATION ANALYSIS  
For quality control of genotyped GWAS results, SNPs were flagged with a Hardy-Weinberg 
P<10−20 in Europeans, a minor allele frequency of <0.1%, or a call rate of <90%. SNPs that were 
only genotyped on the 23andMe V1 platform were also flagged, due to limited sample size. 
Genotyped SNPs were also tested for date effects, and flagged SNPs with P<10−50 by ANOVA 
of SNP genotypes against a factor dividing genotyping date into 20 roughly equal-sized buckets. 
For imputed GWAS results, SNPs with avg.rsq<0.5 or min.rsq<0.3 in any imputation 
batch were flagged, as well as SNPs that had strong evidence of an imputation batch effect. The 
batch effect test is an F test from an ANOVA of the SNP dosages against a factor that represents 
imputation batch; results with P<10−50 were flagged. Prior to performing the GWAS, the largest 
subset of the data passing these criteria was identified for each SNP, based on its original 
genotyping platform (either v2+v3+v4, v3+v4, v3, or v4 only) and association test results were 
computed for whichever was the largest passing set.  Consequently, there were no imputed 
results for SNPs that failed these filters.  Across the merged results of genotyped and imputed 
SNPs, logistic regression results that did not converge due to complete separation were flagged. 
4.8 FUNCTIONAL ANNOTATION OF LEAD SNPS USING REGULOMEDB 
Select lead SNPs from the GWAS and regions within the same LD blocks were further annotated 
for variants with putative functional significance using RegulomeDB1 (version 1.1, publicly 
available at regulome.stanford.edu). RegulomeDB is a database which guides interpretation of 
human regulatory variants and includes data from the ENCODE Project71 and more than 962 
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other sources. It has recently been expanded further to stay up-to-date with current ENCODE 
releases72,73 as well as Chromatin States from the Roadmap Epigenome Consortium 
(unpublished) and several other updates. The database employs a scoring system (on a scale 1-6) 
which helps filter for variants most likely to be regulatory or with demonstrated regulatory 
function. The scoring system is further detailed in Table 1.  
 
Table 1. RegulomeDB Scoring System. 
Score Supporting Data Types 
1a eQTL + TF binding + matched TF motif + matched DNase Footprint + DNase peak 
1b eQTL + TF binding + any motif + DNase Footprint + DNase peak 
1c eQTL + TF binding + matched TF motif + DNase peak 
1d eQTL + TF binding + any motif + DNase peak 
1e eQTL + TF binding + matched TF motif 
1f eQTL + TF binding / DNase peak 
2a TF binding + matched TF motif + matched DNase Footprint + DNase peak 
2b TF binding + any motif + DNase Footprint + DNase peak 
2c TF binding + matched TF motif + DNase peak 
3a TF binding + any motif + DNase peak 
3b TF binding + matched TF motif 
4 TF binding + DNase peak 
5 TF binding or DNase peak 
6 Other  
 
Listed are the score and the corresponding data types available to support the assertion of regulatory 
potential.  Variants with scores 1a-1f are likely to affect binding and linked to expression of a gene target. 
Variants with scores 2a-2c are likely to affect binding. Variants with scores 3a-3b are less likely to affect 
binding. Variants with scores 4-6 represent minimal evidence of binding.”Other” data types represent 
more rare forms of evidence. 
 
Lead SNPs were prioritized for further annotation based on the p-value of the lead SNP, 
and the relative density of the most highly associated SNPs in the vicinity of each lead SNP. In 
regions that did not have nearby LD peaks, the boundaries for demarcating the regions of interest 
were also established based on density of associated SNPs. In total, four genomic regions were 
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selected for the annotation study: chromosome 3 (49,360,000–50,100,000 bp), chromosome 15 
(73,240,000–73,640,000 bp), chromosome 4 (111,610,058–111,737,533 bp), and chromosome 4 
(112,755,000–112,895,000 bp).  
Within these regions, all variants were examined for putative regulatory function, defined 
as a score of 3 or less (regulome.stanford.edu, accessed [14 Dec 2014] and updated [29 Mar 
2015]). If a variant with a score of 3 or less fell within a motif, its role within the motif was 
judged to be significant if its location had at least 33% conservation; and the element was 
retained for analysis. This degree of conservation was approximated visually. 
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5.0  RESULTS 
5.1 GWAS IDENTIFIES ONE LOCUS WITH GENOME-WIDE SIGNIFICANCE 
A genome-wide association study of appendectomy was conducted on genomes of 133,680 
individuals; the data were filtered to remove close relatives and included only individuals of 
>97% European ancestry.  The appendectomy phenotype was ascertained based on answers to 
online questionnaires regarding appendectomy; cases answered “yes,” they had had an 
appendectomy (n=18,773), and controls answered “no” (n=114,907). 
The demographics of the study population are shown in Table 2. The proportion of cases 
to controls among the European cohort studied is 16.3% to 83.7%, and is in line with 
approximate expected rates of appendicitis (14%) in urban whites in the United States in 197974, 
and the prevalence of appendicitis in European countries, including over the last thirty years in 
Greece (16.4%)74, and during 1960-1965 in the UK (15-18%)75.  
The GWAS study results were adjusted for age, sex, and the top five principal 
components of ancestry1. The Q-Q plot of the p-values is available in Figure 7.  
(1) 1 The genome-wide association study data showed a female gender bias – women were more likely than 
men to report having had appendectomy (B= 0.32097; P = 1.8×10−86). Since there is a male bias in true 
appendicitis, it is likely that our data set reflects an excess of women who have had incidental 
appendectomy. This is in line with national statistics: prior to 1990, women aged 35-44 had a 12.1-fold 
increased risk of incidental appendectomy (43.8 per 10,000  population per year) relative to men. 
Regardless, the GWAS was corrected for gender.76. Addiss DG, Shaffer N, Fowler BS, Tauxe RV. The 
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One locus met genome-wide significance (p-value < 5 X 10-8):  rs2129979 (p-value 
8.8x10-14). Additionally, eight single nucleotide polymorphisms (SNPs) were highly significant, 
but did not reach the genome-wide significance threshold: rs192656182 (p-value 9.5x10-8), 
rs137882920 (p-value 9.9x10-8), rs2247036 (p-value 1.0x10-7), rs17044095 (p-value 3.2x10-7). 
rs117367662 (p-value 5.3x10-7), rs1650337 (p-value 6.9x10-7), rs75972139 (p-value 7.8x10-7), 
and rs6445791 (p-value 9.6x10-7). Lead SNP rsIDs are reported based on the 
snp137CodingDbSNP schema from the UCSC Genome Browser. These nine index SNPs are 
described in Table 4. The results are also displayed graphically in the Manhattan Plot in Figure 
1. Quality statistics for the index SNPs are shown in Table 3. Regional association plots for the
index SNPs and surrounding regions included in the RegulomeDB annotation analysis are shown 
in Figure 2, Figure 3, Figure 4, and Figure 5. Regional association plots for index SNPs not 
included in the annotation analysis are shown in Figure 8, Figure 9, Figure 10, Figure 11, and 
Figure 12.  
Table 2. Demographics of unrelated, European individuals included in Appendectomy GWAS. 
Phenotype Group Total Male Female Age 0-30 Age 30-45 Age 45-60 Age 60+ 
Appendectomy Case 18,773 8,175 10,598 763 2,702 4,823 10,485 
Control 114,907 59,824 55,083 14,984 33,077 31,761 35,085 
The ages shown represent the age at which patients were genotyped. 
epidemiology of appendicitis and appendectomy in the United States. American journal of epidemiology. 
Nov 1990;132(5):910-925.  
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 Figure 1. Manhattan Plot of GWAS of Appendectomy. 
The nine index SNPs, shown annotated with names of nearest genes, are depicted as a distribution of 
association test statistics versus genomic position. The Y-axis depicts the −log10-transformed P-values 
from the association test; the X-axis depicts the chromosomes 1-22, X and Y. The grey line represents a 
p-value of 5 X 10-8, and the result surpassing this threshold is shown in red. 
 
Table 3. Index SNPs for Strongest Genome-Wide Associations. 
Chromosome SNP rsID Position Allele P value OR (95% CI) SNP 
control/case 
Gene context 
4 rs2129979 111,720,997 G/T 8.8x10-14 0.908 
(0.886,0.932) 
0.7116/ 
0.6943 
PITX2 --- [] 
15 rs192656182 73,599,970 C/T 9.5x10-8 1.453 
(1.272,1.661) 
0.008/ 
0.0104 
NEO1 – [] --HCN4 
20 rs137882920 56,005,258 C/T 9.9x10-8 0.745 
(0.666,0.833) 
0.0178/ 
0.0146 
RBM38--[]--CTCFL 
3 rs2247036 49,882,349 C/T 1.0x10-7 1.065 
(1.040,1.090) 
0.4731/ 
0.4884 
[TRAIP] 
4 rs17044095 112,777,414 G/T 3.2x10-7 1.074 
(1.045,1.104) 
0.7680/ 
0.7787 
[] ---C4orf32 
11 rs117367662 967,822 C/T 5.3x10-7 0.863 
(0.815,0.915) 
0.0603/ 
0.0543 
[AP2A2] 
12 rs1650337 89,770,068 G/T 6.9x10-7 Inf 0.0000/ 
0.0013 
DUSP6--[]---GALNT4 
1 rs75972139 111,373,721 A/G 7.8x10-7 0.800 
(0.733,0.872) 
0.9843/ 
0.9810 
KCNA3---[]--CD53 
3 rs6445791 51,601,982 A/G 9.6x10-7 1.084 
(1.050,1.120) 
0.1660/ 
0.1758 
[RAD54L2] 
Reported are the most-associated SNPs within each associated region for appendectomy cases and 
controls. Gene context graphically depicts the distance between the index SNP (“[]”) and the nearest 
gene; “ “= <1kb, “−“ = <10kb, “--“ = <100kb, “−−−“ = <1000kb. Inf stands for infinity. 
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Figure 2. Regional Association Plot for rs2129979. 
 
Association test results are shown as a distribution of position on chromosome 4 in the vicinity of the 
SNP along the X-axis versus negative transformed −log10 of association test P-values along the left Y-
axis. The symbol “+” indicates a genotyped SNP; “o” indicates an imputed SNP. The colors indicate the 
strength of linkage disequilibrium (LD) with the index SNP. Blue lines indicate the recombination rate 
plotted along the right Y-axis, as a function of genomic position along the X-axis. Genes in the vicinity of 
the lead SNP are shown along the X-axis. The region 111,610,058–111,737,533 bp was chosen for further 
analysis in the RegulomeDB annotation study.  
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 Figure 3. Regional Association Plot for rs192656182. 
Association test results are shown as a distribution of position on chromosome 15 in the vicinity of the 
SNP along the X-axis versus negative transformed −log10 of association test P-values along the left Y-
axis. The symbol “+” indicates a genotyped SNP; “o” indicates an imputed SNP. The colors indicate the 
strength of linkage disequilibrium (LD) with the index SNP. Blue lines indicate the recombination rate 
plotted along the right Y-axis, as a function of genomic position along the X-axis. Genes in the vicinity of 
the lead SNP are shown along the X-axis. The region 73,240,000–73,640,000 bp was chosen for further 
analysis in the RegulomeDB annotation study. 
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 Figure 4. Regional Association Plot for rs2247036.  
Association test results are shown as a distribution of position on chromosome 3 in the vicinity of the 
SNP along the X-axis versus negative transformed −log10 of association test P-values along the left Y-
axis. The symbol “+” indicates a genotyped SNP; “o” indicates an imputed SNP. The colors indicate the 
strength of linkage disequilibrium (LD) with the index SNP. Blue lines indicate the recombination rate 
plotted along the right Y-axis, as a function of genomic position along the X-axis. Genes in the vicinity of 
the lead SNP are shown along the X-axis. The region 49,360,000–50,100,000 bp was chosen for further 
analysis in the RegulomeDB annotation study. 
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 Figure 5. Regional Association Plot for rs17044095. 
Association test results are shown as a distribution of position on chromosome 4 in the vicinity of the 
SNP along the X-axis versus negative transformed −log10 of association test P-values along the left Y-
axis. The symbol “+” indicates a genotyped SNP; “o” indicates an imputed SNP. The colors indicate the 
strength of linkage disequilibrium (LD) with the index SNP. Blue lines indicate the recombination rate 
plotted along the right Y-axis, as a function of genomic position along the X-axis. The region 
112,755,000–112,895,000 bp was chosen for further analysis in the RegulomeDB annotation study. 
 
 
 28 
5.2 IDENTIFICATION OF 299 TARGETS PUTATIVELY REGULATED BY 
ELEMENTS ASCERTAINED USING REGULOMEDB 
The genomic regions examined using RegulomeDB identified a total of 4,579 putative regulatory 
variants. The region on chromosome 15 (73,240,000–73,640,000 bp) returned 1,507 SNPs with 
regulatory potential, of which 40 SNPs had a score of 3 or less, indicating higher potential for 
being regulatory. This region yielded 109 unique targets (eQTL gene targets, protein binding 
targets, or proteins with affinity for specific motifs) potentially regulated by these SNPs.  
The region on chromosome 4 (111,610,058–111,737,533 bp) returned 576 SNPs, of 
which 6 SNPs had a RegulomeDB score of 3 or less, and yielded 13 targets. The region on 
chromosome 3 (49,360,000–50,100,000 bp) returned 1,903 SNPs, of which 132 SNPs had a 
score of 3 or less, and yielded 254 unique targets2. The second region on chromosome 4 
(112,755,000–112,895,000 bp) returned 593 SNPs, of which 21 SNPs had a score of 3 or less, 
and yielded 24 unique targets. 
In total, 921 targets of potentially regulatory elements were identified using RegulomeDB 
(Table 4). The motifs identified along with their targets are organized by chromosomal region 
and available in Table 5 (chromosome 3), Table 6 (chromosome 15), Table 7 (chromosome 4 at 
111.7 Mb), and Table 8 (chromosome 4 at 112.7 Mb). None of the nine lead SNPs of the GWAS 
were found to have any putative regulatory activity.  
2 This region on chromosome 3 also yielded two dsQTLs (DNase I sensitivity quantitative trait loci), both 
with a score of 1f. dsQTL stands for “DNase I sensitivity QTL” – a location at which DNase sequencing read depth 
correlates significantly with a nearby SNP or insertion/deletion. dsQTLs are typically enriched in predicted 
transcription factor binding sites, and are associated with transcription factor binding changes that are allele-
specific77. Degner JF, Pai AA, Pique-Regi R, et al. DNase I sensitivity QTLs are a major determinant of 
human expression variation. Nature. Feb 16 2012;482(7385):390-394. 
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Many targets of the targets of the identified elements overlapped. Of the 921 targets, 299 
targets were unique across all four chromosomal regions examined. Seven targets were found to 
be putatively regulated by variants within three of four chromosomal regions: EP300, EVI-1, 
FOXJ3, FOXP1, GATA1, HNF4A, and POLR2A. Four were targeted by variants within all four 
chromosomal regions: CEBPB, CTCF, FOS, and RAD21.  
Elements were further stratified based on the distance of their associated putative 
regulatory variant’s distance from the index SNP. Details for elements found near chromosome 3 
are listed in Table 9, those for chromosome 15 in Table 10, those for chromosome 4 (at 111.7 
Mb) in Table 11, and those for chromosome 4 (at 112.7 Mb) in Table 12. 
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6.0  DISCUSSION 
To the best of my knowledge, this was the first GWAS study of appendectomy performed. It 
identified one SNP far surpassing genome-wide significance (rs2129979). Four of the lead SNPs 
from the study and the surrounding regions within the same LD blocks were then further 
annotated for the existence of putative functional variants using RegulomeDB (rs2129979, 
rs192656182, rs2247036, rs17044095). 
The RegulomeDB work identified 299 unique targets of regulatory elements modified by 
variants in the same LD block as the lead SNPs of the GWAS. In addition, four of these targets 
had putative regulatory input from variants in all four regions examined (CEBPB, CTCF, FOS, 
RAD21), and seven targets had putative regulatory input from variants in three of the four 
regions (EP300, EVI-1, FOXJ3, FOXP1, GATA1, HNF4A, POLR2A). POLR2A is the B1 
subunit of RNA Polymerase II; given that there are several protein-coding genes in the vicinity 
of the lead SNPs in all four regions, it is unsurprising that polymerase may be a target of the 
putative regulatory elements in the region. There was also overlap between the targets putatively 
regulated by variants across several chromosomal regions and targets putatively regulated by 
variants which were found nearest to the lead SNPs - within 10 kb: CTCF, RAD21, and within 
50 kb: CEBPB, CTCF, FOS, RAD21, EP300, GATA1, HNF4A, and POLR2A.  
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6.1 IDENTIFICATION OF TARGETS THAT INTERACT WITH KNOWN KEY 
PLAYERS IN THE INFLAMMATORY RESPONSE IN APPENDICITIS: IL-8, IL-1B 
AND IL-6 
Several targets of putative regulatory elements were found to interact with known inflammatory 
markers of appendicitis, and will be described below. CEBPB (CCAAT/Enhancer Binding 
Protein, beta) is a transcription factor with a key role in the regulation of genes involved in the 
immune and inflammatory responses78. According to the RegulomeDB analysis, it is putatively 
regulated by rs576813 which is 11,588 bp from the lead SNP on chromosome 15, with a score of 
2b (“likely to affect binding”). It is also putatively regulated by rs9814765 which is 63,794 bp 
from the lead SNP on chromosome 3, with a score of 2c (“likely to affect binding”); there are 
additional SNPs with putative regulatory activity of CEBPB in this region of interest farther than 
this. CEBPB is also putatively regulated by rs7434417 which is 12,559 bp from the lead SNP on 
chromosome 4 (at 111.7 Mb), with a score of 3a (“less likely to affect binding”). Finally, CEBPB 
is putatively regulated by rs7569015, located 98,642 bp from the lead SNP on chromosome 4 (at 
112.7 Mb), also with a score of 3a. 
FOS is a regulator of cell proliferation, differentiation, and transformation, and has roles 
in stress response and apoptosis79-81. It is putatively regulated by rs2252833 which is 121,860 bp 
from the lead SNP on chromosome 3 with a score of 1d (“likely to affect binding and linked to 
expression of a gene target”), along with several other SNPs at more distant locations within this 
region of interest. It is also putatively regulated by rs576813 which is 11,588 bp from the lead 
SNP on chromosome 15, with a score of 2b (“likely to affect binding”), along with several SNPs 
at more distant locations within this region of interest. It is putatively regulated by rs7434417 
and rs7439625, which are 12,559 bp and 57,519 bp away from the lead SNP on chromosome 4 
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(at 111.7 Mb) with scores of 3a for both (“less likely to affect binding”). Finally, it is putatively 
regulated by rs7289990, rs7674382, and rs757507, which are 65,676 bp, 67,788 bp and 105,786 
bp away from the lead SNP on chromosome 4 (at 112.7 Mb) with scores of 3a, 2b and 3a. 
According to StringDB (a protein-protein interaction database82 that has been used previously to 
prioritize genes identified in GWAS studies83), CEBPB interacts with other proteins from the 
RegulomeDB data set: PPARG, SPI1, and MYC.  
IL-8 is the predominant chemokine/cytokine that is upregulated in mild appendicitis31.  
IL-8 is also the only chemokine/cytokine that is upregulated in severe appendicitis, although IL-1 
and IL-11 are also differentially expressed in severe vs mild appendicitis. Because its expression 
is upregulated in both severe and mild appendicitis, it is predicted that IL-8 plays a central role in 
appendicitis pathogenesis31. Interestingly, according to StringDB, both CEBPB and FOS interact 
directly with interleukin 8 (IL-8). JUN and NFKB1, two other proteins within the RegulomeDB 
data set, also interact directly with IL-8 (FOS and JUN can work together as part of the inducible 
transcription complex AP-1).  
It has been reported that in acute appendicitis, a very targeted innate immune response is 
mounted that includes Interleukin-1, beta (IL-1B, a pro-inflammatory cytokine), but not TNF, 
although both are strongly induced in response to products of bacteria such as LPS31. According 
to StringDB, of the 10 displayed proteins that IL-1B interacts directly with, three are encoded by 
genes represented in the RegulomeDB analysis: FOS, JUN, and NFKB1.  
Serum levels of interleukin-6 (IL-6) have been found to be elevated in individuals with 
appendicitis, however IL-6 was not one of the interleukins upregulated in a comprehensive study 
of inflammatory gene expression in inflamed appendices relative to controls. According to 
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StringDB, of the 10 displayed proteins IL-6 interacts directly with, 6 are represented within the 
RegulomeDB data set: CEBPB, FOS, JUN, NFKB1, STAT1, and STAT3.   
NFKB1 (nuclear factor kappa, beta subunit 1) and NF-IL6 (nuclear factor interleukin-6, 
also known as CEBPB) are known to synergistically activate transcription of the inflammatory 
cytokines implicated in appendicitis, IL-6 and IL-884. In addition, although C/EBP alone only 
weakly binds to the IL-8 promoter, together with NFKB, it displays synergism and cooperativity 
in binding to this promoter. The regulation of IL-8 expression depends on the ratio of cellular 
C/EBP and NFKB85. Virtually all pathways that result in upregulation of IL-8 also indirectly 
elevate AP-1 (made up of FOS/JUN), and NFKB86.  
As was demonstrated above, most of the targets identified after filtering the RegulomeDB 
analysis results for close variant distance and overlap across multiple regions showed evidence 
of interacting with the very specific inflammatory pathways known to be activated in acute 
appendicitis. Thus, this preliminary confirmation of molecular players involved in appendicitis 
demonstrates that the data collected through RegulomeDB show promise as a tool for uncovering 
additional insights into the etiology of appendicitis on a molecular level.  
Many variants studied in this work have low RegulomeDB scores, and correspondingly 
higher likelihood of regulating the genetic elements compiled, and so the entirety of the data can 
be used as a resource for further genetic analysis. However, based on the preceding protein-
protein interaction findings, the following priority list of proteins is proposed for more 
immediate follow-up studies: CEBPB, CTCF, EP300, EVI-1, FOS, FOXJ3, FOXP1, GATA1, 
HNF4A, JUN, MYC, NFKB, PPARG, RAD21, SPI1, STAT1, and STAT3. Bolded proteins are 
ones that were identified based on their association with a motif, while unbolded proteins are 
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those whose binding is affected by putative regulatory elements. A flowchart of the process of 
narrowing down relevant targets from the initial 4,579 regulatory variants is available Figure 6. 
 
Figure 6. Flowchart of RegulomeDB Variant and Target Filtering Process. 
6.2 LIMITATIONS OF THE CURRENT STUDY 
There are several limitations to the GWAS study. The appendectomy phenotype is based on self-
report by individuals, and has not been confirmed with medical records. Thus it is not possible to 
guarantee that all cases of appendectomy were, in fact, true appendectomies. Also, the 
appendectomy outcome is not a perfect substitute for appendicitis. Before the more sensitive 
technologies that aid in the diagnosis of appendicitis today were developed, there were many 
more negative appendectomies for every true case of appendicitis. Thus it is possible that the 
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“false” cases of appendicitis are skewing the GWAS signals identified. However, the rate of 
correct diagnosis has greatly improved over time: currently, one incidental appendectomy is 
performed for every 9 true cases of appendicitis (Michael Morowitz, M.D., FACS, personal 
communication).  
To assess the potential impact of this limitation with respect to the GWAS findings, one 
can examine the age variable in the GWAS – the age at which an individual got genotyped. 
Because appendicitis primarily affects individuals aged 10-19, and this pattern hasn’t changed in 
recent decades5, one might suppose that in general, individuals who were older at the time of 
genotyping had their appendix removed earlier in time than individuals who were younger at the 
time of genotyping. One might then expect that if there was a strong confounding effect of age 
on the data set that there would be a stronger association between the lead SNPs of the GWAS 
and appendectomy in the younger age group at the time of genotyping, given that these 
individuals were more likely to have “true appendicitis,” and a less strong association within 
older age groups. Similarly, individuals who were younger at the age of genotyping may have 
been able to more accurately recall the diagnosis of appendicitis (versus cholecystectomy, for 
example) because they would have had it, on average, more recently than those genotyped at 
older ages. However, the associations identified were not significantly stronger in any particular 
age group, which lends further support to the validity of the SNPs identified. Another limitation 
is that this study was done in a >97% European population, thus the findings in this study may 
not be representative of appendicitis in a different ethnic group.  
There are also several limitations to the RegulomeDB follow-up study. The data 
regarding regulatory effects of polymorphisms found within RegulomeDB has only been verified 
in certain cell types, and may not translate to other cell types. The three types of regulatory 
 36 
mechanisms queried in this study are not exhaustive of all types of regulatory elements, thus the 
regions of interest examined may have other regulatory potential. Finally, examining the role of 
protein-coding genes within the regions of interest was outside the scope of this study. Indeed, 
some of the variants identified in the GWAS, and SNPs in the same LD block with them, do fall 
within protein coding genes, thus it is possible that the SNPs identified have a more direct role in 
the pathogenesis besides regulating a secondary target. Identifying the role of these protein-
coding genes is one of the future research directions discussed below. 
6.3 CONCLUSIONS 
To interpret the appendectomy GWAS findings, RegulomeDB was used to identify a list of 
target genes and proteins putatively regulated by variants in the vicinity of the four prioritized 
lead SNPs of the GWAS. A starting list of 299 unique targets identified based on likelihood of 
being regulated by SNPs in the regions queried was further filtered based on two factors. First, 
the targets were organized based on their putative regulatory variants’ distance from the 
prioritized lead SNPs of the GWAS. This increased the likelihood of the variants identified as 
being potential sources of the GWAS signal. Second, the targets were filtered based on whether 
they were putatively regulated by variants across three or four of the four genomic regions 
identified queried. The resulting identification of genes encoding several interaction partners of 
inflammatory factors known to have strong associations with appendicitis lends support to the 
validity and potential of this independent discovery method. 
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6.4 FUTURE RESEARCH DIRECTIONS 
The immediate goal of future studies will be to replicate the SNPs correlated with increased or 
decreased risk of developing appendicitis. A follow-up collaborative replication study involving 
the lab of Dr. Michael Morowitz of Children’s Hospital of Pittsburgh of UPMC and the 
University of Cincinnati Children’s Hospital that genotypes appendicitis subjects and controls at 
the SNPs identified in the GWAS study is ongoing.  
An additional means of advancing this compiled resource of priority SNPs from 
RegulomeDB is to integrate it with other publicly available bioinformatics tools for annotation of 
non-coding variants, such as dbPSHP, CADD, and GWAVA. This method has been shown to be 
very effective for further refinement of a list of priority SNPs related to irritable bowel disease 
(IBD)87. In addition, as mentioned previously, the motif targets identified in this study refer to 
the transcription factors which are affected by putative regulatory elements within the motifs. A 
follow-up study might examine the genes whose expression is modified by the motifs identified.  
An ongoing study in the lab of Dr. Michael Morowitz is examining the gene expression 
of inflamed and non-inflamed appendices, as well as examining the serum of appendicitis cases 
and controls for putative biomarkers. A custom panel of genes was created for this expression 
study; the list of genes was sourced from prioritized genes based on the RegulomeDB 
annotation, as well as select genes in the vicinity of the lead SNPs from the GWAS. 
These simultaneous analyses may enable elucidation of the specific molecular pathways 
involved in the development of appendicitis, and thus may open the door to improved 
diagnostics, treatments, and novel preventive measures for this common disease. 
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6.5 PUBLIC HEALTH SCREENING FOR SUSCEPTIBILITY TO ACUTE 
APPENDICITIS 
Given the high prevalence of acute appendicitis, the emergent nature of its presentation, and the 
lack of specificity in current diagnostic testing, it is worthwhile to consider a personalized public 
health program that integrates individual genetic polymorphisms to improve the care of 
individuals at risk for the disease. This is especially timely: President Barack Obama recently 
announced a $215 million investment into the Precision Medicine Initiative, a program which 
aims to integrate genomic advances into clinical care and public health, and to fund further 
genomics research88. The aim of the appendicitis public health screening program would be to 
pre-emptively identify individuals at increased risk for appendicitis in order to improve 
diagnostic accuracy in case of appendicitis symptoms, and to empower individuals to invest in 
and manage their health. Identifying at-risk individuals would be especially beneficial given that 
appendicitis is most commonly a pediatric affliction, and children may not have the vocabulary 
nor the insight to articulate its symptoms, nor discern them from those of common stomach 
aches.  
Appendicitis is a complex disease with genetic, bacterial, nutritional, and other 
environmental components, thus a thorough screening program would address multiple factors 
involved in its etiology.  
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6.5.1 Creation of a Mathematical Model for Calculation of Risk of Developing 
Appendicitis and Population Health Assessment 
Polymorphism data can be used in conjunction with other risk factor data to develop a 
mathematical model for the likelihood of developing appendicitis at a point in time – a type of 
Alvarado score for asymptomatic individuals, one that can fluctuate over the course of a patient’s 
life depending on the risk factors present. Genetic screening would consist of genotyping the 
SNPs identified in the GWAS known to influence the risk of developing the condition (if these 
SNPs are replicated in future studies and shown to be valid across populations). Because there is 
no risk for neonatal presentation of appendicitis, the voluntary genetic screening portion of the 
program would be instituted at an early pediatric appointment. 
In a parallel effort, known risk factors for developing appendicitis would be collected on 
the child and their family. First and foremost, a family history of appendicitis would be collected 
and entered into the electronic medical record.  If validated in further studies, risk factors that 
have been reported in the literature, such as breast feeding duration, would also be collected.  It 
is known that the primary microbe associated with appendicitis is also associated with other 
adverse health outcomes like periodontal disease, and preterm labor. Although a family history 
of these conditions has not been examined with respect to risk of appendicitis to date, there exists 
a plausible connection, and if validated, can be included in the family history questionnaire. 
Other risk factors to include could involve a recent move of the family from a developing 
country, given that this could mask the predisposition to appendicitis in previous generations and 
give a falsely reassuring family history. This family history would be updated at each visit for 
new factors, such as a later tonsillectomy (if its association with tonsillectomy is replicated). 
Although many of the preceding risk factors listed have only been reported once in the literature, 
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it would not be costly to confirm their associations with the outcome of appendicitis within 
existing data sets. Next, principal component analysis of the genetic, family history, and 
environmental risk factors could be used to create a predictive model of the risk of appendicitis 
in the patient. The individuals would then be stratified according to their risk based on this 
model. Those with risk surpassing a defined threshold would be flagged for follow-up counseling 
regarding their risk factors and their potential mitigation. This high-risk status would also be 
prominently featured in the individual’s electronic medical record (EMR) for consideration in the 
event of appendicitis-like symptoms. 
A key component of the optimal use of the risk figure in emergent situations would be its 
integration into existing algorithms for the diagnosis of appendicitis with the aim of achieving 
higher diagnostic accuracy than current imaging. To ensure that emergency room physicians and 
surgeons are confident in the clinical benefits of using the risk figure, additional education and 
medical conference presentations would be provided. 
6.5.2 Integration of Appendicitis Risk Data into EMRs and Patient Access 
Previous translational efforts of integrating polymorphism data into clinical care have been met 
with certain challenges. Firstly, when genetic testing is provided at the point-of-care, there are 
delays in its utilization for clinical decision-making. This barrier would be unacceptable for acute 
appendicitis, given its rapid onset and the short timeframe for diagnosis to minimize the risk of 
perforation. Secondly, these translational efforts have shown that there is clinician uncertainty 
regarding the clinical and economic benefits of using polymorphism data to guide decision-
making89. Both of the preceding concerns could be mitigated by preemptively genotyping the 
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patients, and providing risk analysis in advance of emergent situations, as well as providing 
necessary provider education. 
The results of the genetic screen, family history, and final risk figure would be entered 
into the electronic medical record (EMR) of the patient, in accordance with the “Meaningful 
Use” requirement of the Health Information Exchange (HIE), the US government’s initiative to 
allow patients and providers secure and rapid sharing of medical information electronically90. 
Should the individual in question report to the emergency department for gastrointestinal issues, 
the risk figure would aid the clinician in diagnosis.  
The risk figure would be addressed by the primary care provider (PCP) at the high-risk 
patient’s subsequent appointment: the patient and/or their caregiver would be educated on the 
symptoms of appendicitis. This risk figure would be further accessible over the internet through 
the patient’s electronic medical record, along with resources like videos and further information 
on the condition. These electronic resources and the PCP conversation would promote risk-
mitigating behavior change, such as recommending increased fiber intake, or promoting breast 
feeding on the part of the mother in future pregnancies. Knowledge of increased personal 
susceptibility to a condition can have a positive effect on individuals’ behavior from the 
standpoint of prevention. Indeed, receipt of personalized dietary recommendations based on 
individuals’ polymorphisms has been shown to effect positive long-term changes in certain 
nutritional intakes91. 
6.5.3 Targeted Screening Over the High-Risk Patient’s Life Course: Microbial Factors  
A strong association exists between the presence of Fusobacterium nucleatum within the 
appendix and acute appendicitis, but the appendix is clearly not readily accessible for direct 
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microbiological assessment for this risk factor. Nevertheless, it is known that microbiological 
disturbances in certain anatomical niches during states of disease can be reflected in microbial 
changes in adjacent, more readily accessible niches. For example, the diversity of the vaginal 
microbiome correlates with risk for preterm labor caused by infections of the reproductive 
tract92, and there is evidence that the skin microbiome of individuals with diabetes has greatly 
increased amounts of Staphylococcus aureaus93, while intestinal microbial diversity is 
decreased94. Furthermore, it was recently demonstrated that Type II Diabetes is associated with 
increased amounts of bacteria in serum, possibly due to translocation from the gut to the 
bloodstream95. Thus, given that there are known microbial changes associated with appendicitis, 
it is imperative to identify microbial biomarkers for appendicitis in more readily accessible 
sources, like stool or serum. If such a marker is identified, it could be assayed on a regular basis 
in high-risk individuals. Modern next generation sequencing methods and corresponding 
analytical pipelines are now capable of identifying the microbial composition of biological 
samples within 5 to 16 hours96, in contrast with cell culture methods that can take several days. 
Interestingly, an increased amount of F. nucleatum in stool samples has been associated with 
colorectal cancer (CRC), and irritable bowel disease (IBD)97. Protocols for identifying and 
quantifying Fusobacterium nucleatum in stool as a sensitive and specific screen for colorectal 
cancer have already been developed and patented98, and may be of use for developing screening 
for appendicitis within other microbial niches. Unfortunately, in patients with appendicitis, the 
more easily accessible microbiomes of the oral cavity and of stool do not reflect an increase in F. 
nucleatum above expected levels (Michael Morowitz, M.D., FACS, unpublished data), thus other 
niches may be necessary to explore for microbial screening, such as the blood. 
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Depending on the sensitivity and specificity of the developed screening, periodic 
assessment of the microbial biomarkers, or blood biomarkers of the microbial imbalance in at-
risk individuals could be incorporated into the mathematical risk model for appendicitis. Regular 
microbial stool or serum analysis could be made more convenient to the at-risk population 
through the use of local sequencing stations in existing locations like pharmacies. Indeed, a 
private company already exists that provides rapid, inexpensive blood-based multi-analyte 
diagnostics through stations at local pharmacies, and it is working on pathogen detection as part 
of its pipeline99,100. Critics of technology that allows for patient self-testing such as this make the 
valid point that harm could result to the patient if the patient is left to interpret their own test 
results100. Therefore, it would be critical that the microbial screening results be automatically 
input into the patient’s medical record and integrated with the global risk figure, and the 
physician notified of an abnormal result. 
To ensure optimal integration of the screening and results into patient care, several focus 
groups would be held to query which geographic locations would be best for the supplementary 
microbial screening, and the preferred method of educating the patient and their family regarding 
their risk and prevention resources on a continual basis.  
6.5.4 Screening Follow-Up, Surveillance, and Further Research 
As outlined above, following ascertainment, the high-risk patient would be counseled regarding 
their risk and risk mitigation in person and using electronic methods, as well as using any other 
cost-effective methods identified through the focus group studies. Abnormal values on 
supplementary screening, and extended absence of screening would be reported to the PCP.  
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Population data related to risk figures, screening participation, and outcomes would be 
collected to surveil and evaluate to what extent the program is effective at reducing appendicitis 
incidence, reducing negative appendectomy rates, and reducing rates of perforated appendicitis.  
A key function of public health is to conduct research to find new or improved solutions 
to existing public health problems. In the context of appendicitis, the initial priority would be to 
confirm the preliminary genetic and environmental risk factors to enable more precise 
elucidation of individual risk, as well as to better understand epistatic interactions among the 
group of associated SNPs. An additional effort would involve the integration of this risk figure 
into existing diagnostic algorithms used in emergency departments.  
To gauge an individual’s risk over time and to monitor treatment, the development of 
microbial or other biomarkers must be developed. Fortunately, the National Institute of Health’s 
(NIH) Human Microbiome Project along with the European MetaHIT are involved in 
systematically studying the structure and function of the human gut microbiome, and this should 
be of use in helping to identify promising biomarkers of disease like appendicitis. However, 
these projects do not currently focus on identifying changes in the blood microbiome, which has 
been implicated in other diseases involving dysbiosis of the gut101, thus it may be fruitful to 
pursue study of blood-based microbial screening methods for appendicitis.  
Last but not least, an important research effort would entail designing effective 
preventive interventions for the high-risk population. This might include enacting novel 
programs to promote improved diet and increase breastfeeding rates and duration, or targeting 
existing evidence-based public health interventions addressing these factors to this subgroup of 
individuals. Additional research into interventions to mitigate the microbial component of the 
disease would also be warranted. For example, fecal transplantation has been used to treat other 
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intestinal infections such as Clostridium difficile with excellent results, and inflammatory 
conditions such as IBD102.  It would be plausible that a similar intervention could ameliorate 
disturbed flora in the context of a patient at high risk for appendicitis. Additional treatments to 
further investigate might involve antibiotics or targeted probiotics to address the microbial 
component of the disease.   
A broad effort to address this common disease would involve public and private 
stakeholders, including public health departments, governmental programs that have bearing on 
nutrition and determination of individual microbiomes like Women, Infants, Children (WIC), 
healthcare providers - especially pediatric ones, existing academic researchers, and private 
companies involved in developing human and microbial sequencing technologies, as well as 
researchers or companies involved in developing therapeutics to address disturbances of the 
microbiome103.  
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APPENDIX A: ADDITIONAL FIGURES AND TABLES 
Table 4. Putative Regulatory Elements in the Vicinity of the Four Lead SNPs. 
Chromosome Coordinate  rsID Score Protein eQTL Motif 
  (1-based) 
    
  
chr3 49361791 rs13078949 1f 
 
WDR6   
chr3 49365269 rs6795772 1f 
 
MON1A   
  
    
P4HTM   
  
    
WDR6   
  
   
CTCF 
 
  
chr3 49366741 rs9863142 1f 
 
RNF123   
  
    
USP4   
chr3 49370544 rs9883813 3a 
  
FOXP3 
  
     
Nkx2-6 
  
   
CEBPB 
 
  
chr3 49378088 rs4955430 1f 
 
APEH   
  
    
P4HTM   
chr3 49382444 rs200101441 3a 
  
HeliosA 
  
     
IRF3 
  
     
PU.1 
  
     
Tcfap2e 
  
   
IKZF1 
 
  
  
   
NFATC1 
 
  
  
   
PML 
 
  
  
   
POLR2A 
 
  
  
   
STAT5A 
 
  
chr3 49382614 rs113239747 2b 
  
NFE2L2 
  
   
ATF2 
 
  
  
   
BATF 
 
  
  
   
BCL11A 
 
  
  
   
CEBPB 
 
  
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
 
   
EBF1 
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EP300 
 
  
  
   
FOXM1 
 
  
  
   
GATA2 
 
  
  
   
IKZF1 
 
  
  
   
IRF4 
 
  
  
   
MEF2A 
 
  
  
   
MEF2C 
 
  
  
   
NFATC1 
 
  
  
   
NFIC 
 
  
  
   
NFKB1 
 
  
  
   
PAX5 
 
  
  
   
PML 
 
  
  
   
POLR2A 
 
  
  
   
POU2F2 
 
  
  
   
RUNX3 
 
  
  
   
SMARCA4 
 
  
  
   
SP1 
 
  
  
   
SPI1 
 
  
  
   
STAT5A 
 
  
  
   
TAF1 
 
  
  
   
TBP 
 
  
  
   
YY1 
 
  
chr3 49382925 rs9818758 1f 
 
RNF123   
  
   
CEBPB 
 
  
  
   
GATA2 
 
  
  
   
IKZF1 
 
  
  
   
NFATC1 
 
  
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
 
   
NFKB1 
 
  
  
   
PML 
 
  
  
   
POLR2A 
 
  
  
   
SMARCA4 
 
  
  
   
STAT5A 
 
  
  
   
TAF1 
 
  
  
   
TBP 
 
  
chr3 49383642 rs78574069 3a CEBPB 
 
  
  
   
CEBPD 
 
  
  
   
HNF4G 
 
  
  
   
TCF7L2 
 
  
  
   
TEAD4 
 
  
chr3 49389143 rs56101322 2b 
  
MEF-2 
  
   
CEBPB 
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FOS 
 
  
  
   
FOSL2 
 
  
  
   
SPI1 
 
  
chr3 49390250 rs17650792 1f 
 
QARS   
  
    
WDR6   
  
   
POLR2A 
 
  
chr3 49393267 rs8179172 3a 
  
E2F2 
  
     
Nanog 
  
   
POLR2A 
 
  
chr3 49394834 rs1050450 3a 
  
AP-4 
  
   
POLR2A 
 
  
chr3 49396360 rs3811699 2b 
  
MZF1 
chr3 49396751 rs3448 1b 
  
RP58 
  
    
APEH   
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
 
    
P4HTM   
  
   
ERG 
 
  
chr3 49397284 rs8179164 2b 
  
GATA-2 
  
   
CTCF 
 
  
  
   
FOS 
 
  
  
   
FOSL2 
 
  
  
   
GATA1 
 
  
  
   
JUN 
 
  
  
   
JUND 
 
  
chr3 49411404 rs7621003 1f 
 
QARS   
  
    
WDR6   
chr3 49423976 rs6797765 1a 
 
QARS   
  
    
WDR6   
  
   
CEBPB 
 
  
chr3 49425180 rs138478251 2b 
  
Elf3 
  
     
Foxd3 
  
     
FOXP1 
  
     
Srf 
  
     
Tcfap2e 
  
     
Zfp105 
  
     
FOXC1 
  
     
FOXD3 
  
   
FOS 
 
  
chr3 49439440 rs2140270 1f 
 
APEH   
  
    
P4HTM   
chr3 49439725 rs2177268 1f 
  
FOXP1 
  
    
AMT   
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chr3 49443081 rs13096474 1f 
 
AMT   
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
 
    
APEH   
  
    
NCKIPSD   
  
    
NICN1   
  
    
P4HTM   
  
    
WDR6   
chr3 49448583 rs79186983 2b 
  
FOXJ3 
  
     
FOXO1 
  
     
FOXP1 
  
     
FOXK1 
  
     
Srf 
  
   
POLR2A 
 
  
chr3 49448659 rs4855875 3a 
  
FIGLA 
  
   
POLR2A 
 
  
  
   
RBBP5 
 
  
  
   
SIN3A 
 
  
chr3 49448785 rs4855874 3a 
  
FOXG1 
  
   
HNF4A 
 
  
  
   
POLR2A 
 
  
  
   
RBBP5 
 
  
  
   
SIN3A 
 
  
  
   
UBTF 
 
  
chr3 49448818 rs6777731 3a 
  
Sp100 
  
   
E2F1 
 
  
  
   
HNF4A 
 
  
  
   
POLR2A 
 
  
  
   
RBBP5 
 
  
  
   
SIN3A 
 
  
  
   
UBTF 
 
  
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
chr3 49449638 rs940045 1f 
 
APEH   
  
    
P4HTM   
chr3 49449685 rs139004176 2b 
  
NRF1 
chr3 49450864 rs6784820 1f 
 
AMT   
  
    
NICN1   
  
    
QARS   
  
    
WDR6   
  
   
CTCF 
 
  
  
   
MAX 
 
  
  
   
MYC 
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RAD21 
 
  
  
   
USF1 
 
  
chr3 49453834 rs6997 1f 
 
USP4   
  
   
EBF1 
 
  
  
   
ELF1 
 
  
  
   
FOXP2 
 
  
  
   
MYC 
 
  
  
   
NFATC1 
 
  
  
   
NFIC 
 
  
  
   
PML 
 
  
  
   
POLR2A 
 
  
  
   
RUNX3 
 
  
  
   
SIN3A 
 
  
  
   
SPI1 
 
  
chr3 49454112 rs9814873 1f 
 
USP4   
  
   
NFIC 
 
  
  
   
EBF1 
 
  
chr3 49455330 rs11715915 1f 
 
USP4   
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
 
   
POLR2A 
 
  
  
    
QARS   
  
    
WDR6   
chr3 49459114 rs4855873 1d 
 
QARS   
  
    
WDR6   
  
   
NFIC 
 
  
  
   
PML 
 
  
chr3 49459252 rs1464567 1f 
 
AMT   
  
    
NICN1   
  
    
USP19   
  
    
WDR6   
  
   
PML 
 
  
  
   
POLR2A 
 
  
chr3 49459376 rs1464566 1b 
 
QARS   
  
    
WDR6   
  
   
FOXA2 
 
  
  
   
POLR2A 
 
  
chr3 49460350 rs1464569 1f 
 
APEH   
  
    
P4HTM   
  
   
EP300 
 
  
  
   
ESRRA 
 
  
  
   
FOXA1 
 
  
  
   
FOXA2 
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HDAC2 
 
  
  
   
HNF4A 
 
  
  
   
MAX 
 
  
  
   
MXI1 
 
  
  
   
MYBL2 
 
  
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
 
   
POLR2A 
 
  
  
   
RXRA 
 
  
  
   
SP1 
 
  
  
   
TBP 
 
  
  
   
TEAD4 
 
  
chr3 49460407 rs8897 1d 
 
AMT   
  
    
APEH   
  
    
NCKIPSD   
  
    
NICN1   
  
    
P4HTM   
  
    
WDR6   
  
   
ESRRA 
 
  
  
   
FOXA1 
 
  
  
   
FOXA2 
 
  
  
   
HNF4A 
 
  
  
   
MAX 
 
  
  
   
MXI1 
 
  
  
   
MYBL2 
 
  
  
   
POLR2A 
 
  
  
   
RXRA 
 
  
  
   
TBP 
 
  
  
   
TEAD4 
 
  
chr3 49465162 rs73088161 3a 
  
AR 
  
   
FOS 
 
  
  
     
Zbtb3 
  
   
FOXA1 
 
  
  
   
FOXA2 
 
  
chr3 49497743 rs76711745 3a TFAP2A 
 
  
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
chr3 49497883 rs885592 1d 
  
Zbtb3 
  
    
QARS   
  
    
WDR6   
  
   
TFAP2A 
 
  
  
   
TFAP2C 
 
  
chr3 49499167 rs11130197 2b 
  
ZNF75A 
 52 
  
   
CHD1 
 
  
  
   
CTCF 
 
  
  
   
EP300 
 
  
  
   
HNF4A 
 
  
  
   
RAD21 
 
  
  
   
RBBP5 
 
  
  
   
SIN3A 
 
  
  
   
SP1 
 
  
  
   
TAF1 
 
  
  
   
TBP 
 
  
  
   
TCF12 
 
  
  
   
TEAD4 
 
  
  
   
TFAP2C 
 
  
  
   
YY1 
 
  
chr3 49499829 rs10865955 1f 
 
QARS   
  
    
WDR6   
  
   
AR 
 
  
  
   
ATF1 
 
  
  
   
EP300 
 
  
  
   
FOSL1 
 
  
  
   
FOXA1 
 
  
  
   
JUN 
 
  
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
 
   
JUND 
 
  
chr3 49502504 rs139173102 2b CEBPB 
 
  
  
   
FOS 
 
  
chr3 49502548 rs149926066 3a 
  
aMEF-2 
  
     
Cdx 
  
     
FOXC1 
  
     
FOXC2 
  
     
Foxl1 
  
     
FOXP1 
  
     
HNF3alpha 
  
     
HNF3beta 
  
     
MEF-2 
  
     
ONECUT3 
  
     
Elf3 
  
     
Srf 
  
   
CEBPB 
 
  
  
   
FOS 
 
  
chr3 49503625 rs80267491 3a 
  
ESRRB 
  
   
FOXA2 
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GATA1 
 
  
  
   
HNF4A 
 
  
  
   
POLR2A 
 
  
  
   
TFAP2A 
 
  
chr3 49506900 rs9860055 1f 
 
APEH   
  
    
P4HTM   
  
   
MTA3 
 
  
  
   
POLR2A 
 
  
  
   
RFX3 
 
  
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
 
   
SIN3A 
 
  
  
   
SMARCB1 
 
  
chr3 49507030 rs150568866 2b 
  
Zfp187 
  
     
ZNF524 
chr3 49507668 rs187508379 2b 
  
CNOT3 
chr3 49508971 rs11456203 2b TAL1 
 
  
chr3 49508976 rs7613491 2b TAL1 
 
  
chr3 49521974 rs4855864 1f 
  
E2F3 
  
    
QARS   
  
    
WDR6   
chr3 49522822 rs115890970 2b 
  
HOXD3 
  
     
IPF1 
  
   
BHLHE40 
 
  
  
   
EP300 
 
  
  
   
NFIC 
 
  
chr3 49535115 rs7637999 1f 
 
QARS   
  
    
WDR6   
chr3 49538799 rs11130199 1f 
 
QARS   
  
    
WDR6   
  
   
CEBPB 
 
  
  
   
EP300 
 
  
  
   
FOS 
 
  
  
   
GATA1 
 
  
  
   
JUND 
 
  
  
   
MYBL2 
 
  
  
   
POLR2A 
 
  
  
   
TAL1 
 
  
chr3 49540389 rs79873387 3a FOS 
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chr3 49546864 rs78407378 3a 
  
BCL6 
  
   
FOXA2 
 
  
 54 
  
   
HNF4A 
 
  
chr3 49550481 rs186347793 3a 
  
Foxj3 
  
   
GATA6 
 
  
chr3 49555583 rs13322887 1f 
 
APEH   
  
    
P4HTM   
chr3 49557051 rs3870338 1f 
 
AMT   
  
    
NICN1   
  
    
QARS   
  
    
WDR6   
chr3 49557857 rs3870336 1f 
 
ARIH2   
  
    
DAG1   
  
    
RBM6   
chr3 49570882 rs1050088 1f 
 
AMT   
  
    
NICN1   
  
    
QARS   
  
    
WDR6   
chr3 49571462 rs12583 1f 
 
APEH   
  
    
P4HTM   
chr3 49572140 rs4625 2b 
  
Bach1 
  
   
CEBPB 
 
  
chr3 49572403 rs11538155 2b 
  
MAZR 
  
     
Zfp281 
  
   
CEBPB 
 
  
chr3 49572894 rs6446283 3a 
  
HNF4A 
  
   
EP300 
 
  
  
   
MAX 
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MXI1 
 
  
  
   
SIN3A 
 
  
  
   
YY1 
 
  
chr3 49574808 rs13079082 3a 
  
LUN-1 
  
   
CEBPB 
 
  
chr3 49577592 rs74426367 2c 
  
Tcfap2b 
  
     
Tfap2c 
chr3 49577665 rs1982861 1f 
 
APEH   
  
    
P4HTM   
chr3 49577960 rs78040846 2b 
  
Ikaros 
  
     
Sox13 
chr3 49581559 rs10865956 1f 
 
APEH   
  
    
P4HTM   
chr3 49591539 rs115713947 3a 
  
Irf4 
chr3 49598064 rs9862534 1f 
 
APEH   
 55 
  
    
P4HTM   
chr3 49600319 rs4241407 1f 
 
AMT   
  
    
APEH   
  
    
NCKIPSD   
  
    
NICN1   
  
    
P4HTM   
  
    
WDR6   
  
   
AR 
 
  
chr3 49600426 rs4241406 2b 
  
Mrg2 
  
     
TFAP4 
  
     
TGIF 
  
     
TGIF1 
  
     
Tgif2 
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
 
   
AR 
 
  
chr3 49601255 rs2312462 1f 
 
AMT   
  
    
APEH   
  
    
NCKIPSD   
  
    
NICN1   
  
    
P4HTM   
  
    
WDR6   
chr3 49625093 rs72936019 2a 
  
FOXG1 
  
     
NF-Y 
  
     
NFYA 
chr3 49639803 rs1491983 1d 
  
AP-4 
  
     
Lmo2complex 
  
    
RHOA   
  
   
ESR1 
 
  
  
   
TFAP2A 
 
  
chr3 49645209 rs11130211 1f 
 
HEMK   
chr3 49646981 rs2029591 1f 
 
AMT   
  
    
NICN1   
  
    
RHOA   
  
    
WDR6   
chr3 49649434 rs9823134 2b FOS 
 
  
chr3 49655927 rs62262672 3a 
  
FOXP3 
  
   
REST 
 
  
chr3 49657441 rs4855833 1f 
 
RHOA   
chr3 49658084 rs13096480 1f 
 
COX4NB   
  
   
EGR1 
 
  
chr3 49665390 rs2131108 1f 
 
AMT   
  
    
NICN1   
 56 
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RHOA   
chr3 49667691 rs9883000 1f 
 
NICN1   
  
    
RHOA   
chr3 49674343 rs9824435 1f 
 
NICN1   
  
    
RHOA   
  
   
FOS 
 
  
chr3 49679072 rs2329021 1f 
 
RHOA   
chr3 49685073 rs2329020 1f 
 
WDR6   
chr3 49685592 rs1078341 1b 
  
HMX2 
  
     
HMX3 
  
     
Nkx2-4 
  
     
Nkx2-6 
  
    
NICN1   
  
    
RHOA   
  
   
MYC 
 
  
  
   
USF1 
 
  
chr3 49687779 rs6774202 1b 
  
HP1sitefactor 
  
    
RHOA   
  
   
BATF 
 
  
  
   
NFKB1 
 
  
  
   
RUNX3 
 
  
  
   
ZNF263 
 
  
chr3 49690199 rs4855885 1f 
 
RHOA   
  
   
ZNF263 
 
  
chr3 49696633 rs2131104 1f 
 
WDR6   
chr3 49696797 rs11718165 1f 
 
C3orf62   
  
    
DAG1   
  
    
HSS00328072 
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MST1   
  
    
USP4   
chr3 49701298 rs2005557 2b 
  
NRSF 
  
     
REST 
  
   
MYC 
 
  
chr3 49701983 rs9858542 1f 
 
USP4   
chr3 49706403 rs187773800 2b 
  
Zfp410 
  
     
Zfp281 
  
     
RREB1 
  
     
CKROX 
  
     
MAZ 
 57 
  
     
SP1 
chr3 49708502 rs1060962 2b MXI1 
 
  
chr3 49708590 rs34560231 3a NFIC 
 
  
chr3 49708769 rs1060970 1b 
  
EWSR1-FLI1 
  
    
AMIGO3   
  
    
GMPPB   
  
    
UBA7   
  
   
EP300 
 
  
  
   
FOXA1 
 
  
  
   
FOXA2 
 
  
  
   
HNF4A 
 
  
  
   
MYBL2 
 
  
  
   
NFIC 
 
  
  
   
RXRA 
 
  
  
   
SP1 
 
  
chr3 49708807 rs35637631 2b EP300 
 
  
  
   
FOXA1 
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FOXA2 
 
  
  
   
HNF4A 
 
  
  
   
MYBL2 
 
  
  
   
NFIC 
 
  
  
   
RXRA 
 
  
  
   
SP1 
 
  
  
   
USF1 
 
  
chr3 49709147 rs71324984 2b 
  
Hbp1 
  
     
Nanog 
chr3 49711430 rs140606103 2b 
  
VDR=CAR=PXR 
chr3 49711559 rs113530503 2b 
  
AP-2 
chr3 49712220 rs111635853 2b 
  
SP1 
  
     
WT1 
  
     
Zfp281 
chr3 49715446 rs4855881 1f 
 
WDR6   
chr3 49719729 rs9822268 3a 
  
SP1 
  
   
POLR2A 
 
  
chr3 49720044 rs34491127 2b 
  
RFX1 
  
   
POLR2A 
 
  
chr3 49720887 rs73834009 3a 
  
EGR1 
  
     
EGR2 
  
     
EGR3 
  
     
EGR4 
  
     
Zif268 
 58 
  
   
NR3C1 
 
  
  
   
POLR2A 
 
  
chr3 49723001 rs201720919 3a POLR2A 
 
  
chr3 49724534 rs41291700 2b 
  
MAF 
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POLR2A 
 
  
chr3 49725859 rs145408661 2b 
  
PLAG1 
  
   
NFIC 
 
  
  
   
POLR2A 
 
  
  
   
TAF1 
 
  
chr3 49726555 rs4052565 2b 
  
CACD 
chr3 49727754 rs140793082 3a 
  
RFX5 
  
   
GATA1 
 
  
  
   
REST 
 
  
  
   
TAL1 
 
  
chr3 49727886 rs7373192 2b REST 
 
  
  
   
TAL1 
 
  
chr3 49735746 rs11130214 1f 
  
SPDEF 
  
    
WDR6   
chr3 49736269 rs79587292 3a GATA1 
 
  
chr3 49737323 rs11130217 1f 
 
RHOA   
chr3 49742107 rs34154145 2b POLR2A 
 
  
chr3 49745235 rs11709734 1f 
 
RHOA   
chr3 49750261 rs77208503 2b SPI1 
 
  
chr3 49751585 rs2291542 1f 
 
WDR6   
chr3 49751856 rs12715437 1f 
 
RHOA   
chr3 49753003 rs34614773 3a 
  
ZIC3 
  
     
ZIC4 
  
     
  
chr3 49753788 rs11720705 1f 
 
RHOA   
  
   
POLR2A 
 
  
chr3 49753901 rs61743872 3a 
  
CAC-bindingprotein 
  
   
POLR2A 
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chr3 49754970 rs7628207 1f 
 
RHOA   
  
   
POLR2A 
 
  
chr3 49755676 rs62640368 2b 
  
CACCC-bindingfactor 
  
   
POLR2A 
 
  
chr3 49756212 rs35201844 2b 
  
Ascl2 
  
     
E2A 
  
   
POLR2A 
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chr3 49758111 rs7634945 2b 
  
ER 
  
     
ESR1 
  
   
POLR2A 
 
  
chr3 49758497 rs34127462 3a 
  
Bcl6b 
  
   
POLR2A 
 
  
  
   
MTA3 
 
  
chr3 49758764 rs4768 2b 
  
YY1 
  
   
MTA3 
 
  
  
   
POLR2A 
 
  
chr3 49760431 rs34345884 2b 
  
NRSF 
  
     
REST 
  
   
POLR2A 
 
  
chr3 49760477 rs11547261 2b 
  
CREB5 
  
     
JDP2 
  
     
Pax-3 
  
   
POLR2A 
 
  
chr3 49761613 rs3811695 1f 
 
(dsQTL)   
chr3 49771990 rs9849038 1f 
 
RHOA   
chr3 49808981 rs11717463 3a 
  
FOXP1 
  
   
MEF2A 
 
  
  
   
RUNX3 
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chr3 49813258 rs9853352 1f 
 
RHOA   
  
    
USP4   
  
    
WDR6   
chr3 49817450 rs9829155 1f 
 
RHOA   
chr3 49818555 rs9814765 2c CEBPB 
 
  
chr3 49823200 rs60844685 3a E2F1 
 
  
  
   
GATA1 
 
  
  
   
MAX 
 
  
  
   
SPI1 
 
  
chr3 49827791 rs55750059 2b 
  
Six-1 
  
     
Six-6 
chr3 49828863 rs145439991 3a 
  
Egr1 
  
   
JUND 
 
  
chr3 49829653 rs7637711 1f 
 
NICN1   
  
    
RHOA   
chr3 49832788 rs73079003 3a 
  
KLF16 
  
     
Klf7 
  
     
Sp1 
  
     
SP3 
  
   
HNF4A 
 
  
 60 
chr3 49834571 rs6809879 1f 
 
RHOA   
chr3 49840525 rs201878414 2b 
  
NFKB1 
chr3 49840843 rs115355405 3a 
  
Meis1 
  
     
Mrg2 
  
     
Pknox1 
  
     
MEIS2 
  
     
Tgif2 
chr3 49841310 rs78926068 3a 
  
NFKB1 
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chr3 49842881 rs11400401 2b 
  
mTERF 
  
     
RREB-1 
  
   
SMARCA4 
 
  
  
   
ETS1 
 
  
  
   
MYC 
 
  
  
   
POLR2A 
 
  
  
   
RAD21 
 
  
  
   
GABPA 
 
  
chr3 49843723 rs3819325 1b 
  
CAC-bindingprotein 
  
     
Egr 
  
     
RREB1 
  
     
SP1 
  
     
SP4 
  
     
Zfp281 
  
     
Zfp740 
  
     
ZNF219 
  
     
ZNF515 
  
     
ZNF740 
  
   
CHD2 
 
  
  
   
ETS1 
 
  
  
   
MYC 
 
  
chr3 49844001 rs72938113 3a 
  
TFAP2C 
  
   
CHD2 
 
  
  
   
EP300 
 
  
  
   
ETS1 
 
  
  
   
GABPA 
 
  
  
   
GATA1 
 
  
  
   
GATA2 
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MAZ 
 
  
  
   
MYC 
 
  
  
   
POLR2A 
 
  
 61 
  
   
RCOR1 
 
  
  
   
SMARCA4 
 
  
  
   
TAL1 
 
  
  
   
TEAD4 
 
  
chr3 49845006 rs58339610 3a 
  
Pknox1 
  
     
PKNOX2 
  
   
ELF1 
 
  
  
   
EP300 
 
  
  
   
NFKB1 
 
  
  
   
PBX3 
 
  
  
   
POLR2A 
 
  
  
   
SMARCA4 
 
  
  
   
TCF12 
 
  
  
   
TCF3 
 
  
chr3 49860854 rs6446298 1f 
  
CART1 
  
    
AK097846   
  
    
APEH   
  
    
RNF123   
  
   
MAFK 
 
  
chr3 49878078 rs2271960 1f 
 
RBM6   
  
   
CTCF 
 
  
chr3 49878113 rs2271961 1f 
 
RBM6   
  
   
CTCF 
 
  
chr3 49878264 rs1996663 1f 
 
AMT   
  
    
NICN1   
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RHOA   
  
   
CTCF 
 
  
chr3 49878395 rs1996664 1f 
 
RHOA   
  
   
CTCF 
 
  
chr3 49878779 rs75160702 3a 
  
FIGLA 
chr3 49880399 rs34484573 2b USF1 
 
  
chr3 49880943 rs1110295 1f 
  
CAC-bindingprotein 
  
    
HEMK   
  
   
TCF7L2 
 
  
chr3 49894030 rs2276864 1f 
 
-   
chr3 49896727 rs111272205 2b 
  
MAZR 
  
     
PPARalpha:RXRalpha 
  
     
SP1 
  
     
UF1H3BETA 
  
   
CTCF 
 
  
chr3 49901060 rs11130222 2b 
  
LUN-1 
 62 
  
     
NHLH1 
  
   
TEAD4 
 
  
chr3 49902160 rs2883059 1d 
 
HYAL3   
  
    
RBM6   
  
   
MAFF 
 
  
  
   
MAFK 
 
  
chr3 49911354 rs77491796 2b 
  
NKX2-3 
  
     
Nkx2-5 
  
     
T 
  
     
TBX20 
  
     
TRUE 
  
   
CDX2 
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CTCF 
 
  
  
   
HNF4A 
 
  
  
   
MXI1 
 
  
  
   
YY1 
 
  
chr3 49915506 rs9862795 2b 
  
DMRT7 
  
   
POLR2A 
 
  
chr3 49918751 rs9813644 1b 
 
MON1A   
  
   
RFX3 
 
  
chr3 49918975 rs58943948 2b POLR2A 
 
  
  
   
RFX3 
 
  
chr3 49920297 rs56352827 2b POLR2A 
 
  
chr3 49924328 rs7615240 2b 
  
AIRE 
  
   
POLR2A 
 
  
chr3 49936102 rs2230590 2b MYC 
 
  
chr3 49936715 rs41291716 2b 
  
ESRRA 
  
     
ESRRG 
  
     
EWSR1-FLI1 
  
     
RARA 
  
     
RARB 
  
     
RARG 
  
   
BHLHE40 
 
  
  
   
CTCF 
 
  
  
   
RAD21 
 
  
  
   
POLR2A 
 
  
chr3 49943570 rs75195683 2b 
  
Egr 
  
     
KROX 
chr3 49945996 rs58025924 2b 
  
LRF 
  
     
Plagl1 
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ZIC1 
  
     
ZIC3 
  
     
ZIC4 
  
   
GATA1 
 
  
  
   
MAZ 
 
  
chr3 49948627 rs201449228 2b 
  
Evi-1 
  
   
GATA1 
 
  
  
   
GATA2 
 
  
  
   
POU5F1 
 
  
  
   
RBBP5 
 
  
chr3 49977786 rs116486986 2b 
  
RNF96 
chr3 49997963 rs2624843 3a GATA1 
 
  
chr3 49998282 rs2883057 3a GATA1 
 
  
chr3 50004209 rs2252833 1d 
 
RBM6   
  
   
FOS 
 
  
  
   
RFX3 
 
  
chr3 50028246 rs2248256 3a 
  
TP53 
  
     
TP63 
  
     
TP73 
  
   
YY1 
 
  
chr3 50039474 rs7628058 1f 
 
RBM6   
chr3 50044006 rs7635601 1f 
 
HYAL3   
  
    
RBM6   
chr3 50082914 rs2526747 1f 
 
HYAL3   
  
    
RBM6   
chr3 50087947 rs144406288 2b EP300 
 
  
  
   
FOS 
 
  
  
   
FOXA1 
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MAFF 
 
  
  
   
MAFK 
 
  
  
   
POLR2A 
 
  
chr3 50098337 rs17050913 1f 
 
HEMK   
chr15 73259907 rs1449270 3a 
  
Eomes 
  
     
TBR1 
  
     
TBX2 
  
   
TRIM28 
 
  
chr15 73260071 rs28440854 3a TRIM28 
 
  
chr15 73260649 rs28666516 3a TCF7L2 
 
  
  
   
TRIM28 
 
  
chr15 73263049 rs8025665 1f 
  
IRF8 
 64 
  
    
KCNS1   
chr15 73275132 rs79403000 3a IKZF1 
 
  
chr15 73275175 rs8033860 3a IKZF1 
 
  
chr15 73275178 rs8034120 3a 
  
PPARG::RXRA 
  
   
IKZF1 
 
  
chr15 73276287 rs4522396 3a FOS 
 
  
chr15 73276395 rs4260030 3a 
  
TTF1(Nkx2-1) 
  
   
FOS 
 
  
chr15 73283449 rs75940106 3a 
  
Barhl2 
  
     
FOXP1 
  
     
HMX2 
  
     
Hmx3 
  
     
Hoxb13 
  
     
ISX 
  
     
LHX9 
  
     
MSX1 
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MSX2 
  
     
Msx3 
  
     
Nkx5-2 
  
     
Nkx6-1 
  
     
PRRX2 
  
     
SHOX2 
  
   
FOS 
 
  
  
   
MYC 
 
  
chr15 73284093 rs11072401 2b 
  
MEF-2 
  
     
MEF2A 
  
     
MEF2B 
  
     
MEF2D 
  
   
STAT3 
 
  
chr15 73284181 rs9920504 1b 
  
Elf-1 
  
    
NEO1   
  
   
FOS 
 
  
  
   
STAT3 
 
  
chr15 73284535 rs9920548 3a CEBPB 
 
  
  
   
FOS 
 
  
chr15 73287152 rs7172316 2b TCF7L2 
 
  
chr15 73287611 rs78572431 3a 
  
HSF1 
  
   
TCF7L2 
 
  
chr15 73290627 rs9920770 3a 
  
Roaz 
  
     
TTF-1(Nkx2-1) 
  
   
MYC 
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STAT3 
 
  
chr15 73290692 rs7496513 3a MYC 
 
  
  
   
STAT3 
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chr15 73290939 rs138108225 3a STAT3 
 
  
chr15 73305445 rs79993429 3a 
  
Gata5 
  
   
IKZF1 
 
  
chr15 73313006 rs28386776 3a HNF4A 
 
  
chr15 73319108 rs76778349 2b 
  
CACD 
  
     
KLF16 
  
     
SP3 
  
     
Spz1 
  
     
UF1H3BETA 
  
     
Zfp281 
  
     
ZNF219 
  
   
MAX 
 
  
chr15 73323136 rs112949915 2b 
  
PPARalpha:RXRalpha 
  
   
RFX3 
 
  
chr15 73327983 rs78424364 3a GATA1 
 
  
chr15 73343331 rs55969660 3a 
  
Oct-4(POU5F1) 
  
   
EZH2 
 
  
chr15 73343578 rs141982291 3a 
  
ZBTB7B 
  
   
EZH2 
 
  
chr15 73343619 rs77667665 3a EZH2 
 
  
chr15 73344196 rs62016793 2b 
  
IRF-2 
  
     
IRF8 
chr15 73347229 rs116353503 3a 
  
FOXP1 
  
   
AR 
 
  
  
   
IKZF1 
 
  
chr15 73371072 rs116463863 3a 
  
EWSR1-FLI1 
  
   
GATA3 
 
  
chr15 73371315 rs68000913 2b 
  
core-bindingfactor 
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chr15 73384345 rs8033192 3a GATA1 
 
  
chr15 73384481 rs77918095 3a GATA1 
 
  
chr15 73406631 rs73440033 3a USF1 
 
  
chr15 73417826 rs8026579 3a CEBPB 
 
  
chr15 73419767 rs9972347 2b 
  
RREB1 
  
     
ZNF784 
chr15 73424712 rs80200465 3a IKZF1 
 
  
chr15 73432078 rs115253960 3a 
  
Hoxa13 
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HOXC13 
  
   
GATA2 
 
  
  
   
GATA3 
 
  
chr15 73443374 rs147723618 3a 
  
ZNF75A 
  
   
CTCF 
 
  
  
   
SPDEF 
 
  
chr15 73466694 rs11636981 3a 
  
TBX15 
  
   
NFKB1 
 
  
chr15 73472096 rs74025262 3b 
  
AR 
  
   
AR 
 
  
chr15 73472104 rs139043297 3b 
  
TEF 
  
   
AR 
 
  
chr15 73513938 rs12373012 3a POLR2A 
 
  
chr15 73513993 rs118016492 3a 
  
UF1H3BETA 
  
   
POLR2A 
 
  
chr15 73524629 rs2046017 3a 
  
FOXJ3 
  
   
MAFK 
 
  
chr15 73530356 rs147551053 2b 
  
NRSE 
  
   
BACH1 
 
  
  
   
EP300 
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GATA2 
 
  
  
   
GATA3 
 
  
chr15 73530599 rs192120450 2b 
  
IRF1 
  
     
Isgf3g 
  
   
BACH1 
 
  
  
   
EP300 
 
  
chr15 73532372 rs1714530 3a 
  
Elk-1 
  
   
CTCF 
 
  
  
   
RAD21 
 
  
chr15 73557903 rs2660825 2b 
  
MRF-2 
  
   
CTCF 
 
  
  
   
CTCF 
 
  
  
   
MYC 
 
  
  
   
MYC 
 
  
  
   
NFATC1 
 
  
  
   
SIN3A 
 
  
chr15 73565650 rs8027588 2b 
  
PRDM1 
  
     
STAT1 
  
   
CTCF 
 
  
chr15 73576507 rs115719976 2b 
  
Evi-1 
  
     
Srf 
 67 
  
   
CTCF 
 
  
  
   
RAD21 
 
  
chr15 73586171 rs41415044 2b 
  
Mtf1 
  
     
NF-AT 
  
   
HDAC2 
 
  
  
   
HNF4A 
 
  
  
   
SP1 
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HNF4A 
 
  
  
   
EP300 
 
  
  
   
HDAC2 
 
  
  
   
SP1 
 
  
chr15 73586267 rs2252725 3a 
  
Zbtb3 
  
   
EP300 
 
  
  
   
FOXA1 
 
  
  
   
FOXA2 
 
  
  
   
HDAC2 
 
  
  
   
HNF4A 
 
  
  
   
HNF4G 
 
  
  
   
JUND 
 
  
  
   
SP1 
 
  
chr15 73586515 rs62015483 3a 
  
RFX1(EF-C) 
  
     
RFX2 
  
     
RFX3 
  
     
RFX4 
  
   
HNF4A 
 
  
chr15 73586577 rs148534572 3a HNF4A 
 
  
chr15 73588382 rs576813 2b 
  
LRF 
  
   
CEBPB 
 
  
  
   
FOS 
 
  
  
   
MAX 
 
  
  
   
MYC 
 
  
chr15 73590153 rs74022931 3a 
  
Nkx2-5 
  
   
IKZF1 
 
  
chr15 73598607 rs531019 2b 
  
FOXfactors 
  
     
HNF3 
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
chr15 73605644 rs11630633 3a 
  
FOXP1 
  
   
BACH1 
 
  
  
   
MAFF 
 
  
  
   
MAFK 
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chr15 73619997 rs494493 2b 
  
RARB 
  
   
IKZF1 
 
  
chr15 73623689 rs572112 3a IKZF1 
 
  
chr15 73623691 rs2680333 3a IKZF1 
 
  
chr15 73624849 rs76789737 2b 
  
p53 
  
     
TP53 
  
   
IKZF1 
 
  
chr15 73632376 rs4776632 3a 
  
Bcl6b 
  
   
CTCF 
 
  
chr4 111656967 rs11944778 3a 
  
ONECUT1 
  
     
ONECUT3 
  
     
Oct-1 
  
     
FOXP1 
  
   
ZNF263 
 
  
chr4 111663478 rs7439625 3a FOS 
 
  
chr4 111677661 rs74843677 3a CTCF 
 
  
  
   
RAD21 
 
  
chr4 111708438 rs7434417 3a CEBPB 
 
  
  
   
FOS 
 
  
  
     
BARX1 
chr4 111714889 rs2220427 2b GATA6 
 
  
  
   
HNF4A 
 
  
chr4 111719978 rs17042198 3a FOXP2 
 
  
chr4 112769004 rs385040 3a CTCF 
 
  
Chromosome Coordinate  rsID Score Protein eQTL Motif 
 
(1-based) 
    
  
 
   
RAD21 
 
  
chr4 112843090 rs72899903 3a FOS 
 
  
chr4 112845202 rs76743823 2b 
  
Foxl1 
  
     
FOXJ2 
  
     
FOXJ3 
  
   
CTCF 
 
  
  
   
FOS 
 
  
chr4 112846378 rs17589101 3a 
  
REST 
  
   
CTCF 
 
  
chr4 112858746 rs7670652 2b 
  
Dobox4 
  
     
Evi-1 
chr4 112865123 rs72899924 2b 
  
GCM 
chr4 112873874 rs115874059 3a 
  
FOXO3A 
  
   
POLR2A 
 
  
chr4 112876056 rs75690152 3a 
  
FOXJ2 
  
   
CEBPB 
 
  
chr4 112881725 rs886567 3a 
  
NGFI-C 
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Egr-2 
EGR1 
Zif268 
GATA3 
POLR2A 
TFAP2A 
GATA1 
SMARCA4 
chr4 112883200 rs757507 3a EP300 
FOS 
Bsx 
SNPs and their corresponding genetic elements with a RegulomeDB score of less than or equal to 3 are 
displayed. 
Table 5. Motifs Identified within the Region of Interest on Chromosome 3 and their Targets. 
Displayed are the position weight matrices (PWMs) of the motifs organized by putative regulatory 
variant. The number of entries of the motif reflects the quantity of sources that identified this motif, if 
greater than one. The red box outlines the location of the putative regulatory variant. RegulomeDB was 
used to retrieve these motifs.                    Table 5 attachment (.xls)
Table 6. Motifs Identified within the Region of Interest on Chromosome 15 and their Targets. 
Displayed are the position weight matrices (PWMs) of the motifs organized by putative regulatory 
variant. The number of entries of the motif reflects the quantity of sources that identified this motif, if 
greater than one. The red box outlines the location of the putative regulatory variant. RegulomeDB was 
used to retrieve these motifs.                   Table 6 attachment (.xls)
Table 7.Motifs Identified within the Region of Interest on Chromosome 4 (at 111.7 Mb) and 
their Targets.  
Displayed are the position weight matrices (PWMs) of the motifs organized by putative regulatory 
variant. The number of entries of the motif reflects the quantity of sources that identified this motif, if 
greater than one. The red box outlines the location of the putative regulatory variant. RegulomeDB was 
used to retrieve these motifs.               Table 7 attachment (.xls)
Table 8. Motifs Identified within the Region of Interest on Chromosome 4 (at 112.7 Mb) and their 
Targets. 
Displayed are the position weight matrices (PWMs) of the motifs organized by putative regulatory 
variant. The number of entries of the motif reflects the quantity of sources that identified this motif, if 
greater than one. The red box outlines the location of the putative regulatory variant. RegulomeDB 
was used to retrieve these motifs.              Table 8 attachment (.xls)
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Table 9. Putative Regulatory Elements Organized by Distance of the Element’s Modifying Variant 
from Lead SNP on Chromosome 3. 
 
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 10 kb 
    
  
3 49880943 1406 rs1110295 1f 
  
CAC-bindingprotein 
  
   
1f 
 
HEMK   
  
   
1f TCF7L2 
 
  
3 49880399 1950 rs34484573 2b USF1 
 
  
3 49878779 3570 rs75160702 3a 
  
FIGLA 
3 49878395 3954 rs1996664 1f 
 
RHOA   
  
   
1f CTCF 
 
  
3 49878264 4085 rs1996663 1f 
 
AMT   
  
   
1f 
 
NICN1   
  
   
1f 
 
RHOA   
  
   
1f CTCF 
 
  
3 49878113 4236 rs2271961 1f 
 
RBM6   
  
   
1f CTCF 
 
  
3 49878078 4271 rs2271960 1f 
 
RBM6   
  
   
1f CTCF 
 
  
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 50 kb 
    
  
3 49894030 11681 rs2276864 1f 
 
(dsQTL)   
3 49896727 14378 rs111272205 2b 
  
MAZR 
  
      
PPARalpha:RXRalpha 
  
      
SP1 
  
      
UF1H3BETA 
  
    
CTCF 
 
  
3 49901060 18711 rs11130222 2b 
  
LUN-1 
  
      
NHLH1 
  
    
TEAD4 
 
  
3 49902160 19811 rs2883059 1d 
 
HYAL3   
  
     
RBM6   
  
    
MAFF 
 
  
  
    
MAFK 
 
  
3 49860854 21495 rs6446298 1f 
  
CART1 
  
     
AK097846   
  
     
APEH   
  
     
RNF123   
  
    
MAFK 
 
  
3 49911354 29005 rs77491796 2b 
  
NKX2-3 
  
      
Nkx2-5 
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T 
  
      
TBX20 
  
      
TRUE 
  
    
CDX2 
 
  
  
    
CTCF 
 
  
  
    
HNF4A 
 
  
  
    
MXI1 
 
  
  
    
YY1 
 
  
3 49915506 33157 rs9862795 2b 
  
DMRT7 
  
    
POLR2A 
 
  
3 49918751 36402 rs9813644 1b 
 
MON1A   
  
    
RFX3 
 
  
3 49918975 36626 rs58943948 2b POLR2A 
 
  
  
    
RFX3 
 
  
3 49845006 37343 rs58339610 3a 
  
Pknox1 
  
      
PKNOX2 
  
    
ELF1 
 
  
  
    
EP300 
 
  
  
    
NFKB1 
 
  
  
    
PBX3 
 
  
  
    
POLR2A 
 
  
  
    
SMARCA4 
 
  
  
    
TCF12 
 
  
  
    
TCF3 
 
  
3 49920297 37948 rs56352827 2b POLR2A 
 
  
3 49844001 38348 rs72938113 3a 
  
TFAP2C 
  
    
CHD2 
 
  
  
    
EP300 
 
  
  
    
ETS1 
 
  
  
    
GABPA 
 
  
  
    
GATA1 
 
  
  
    
GATA2 
 
  
  
    
MAZ 
 
  
  
    
MYC 
 
  
  
    
POLR2A 
 
  
  
    
RCOR1 
 
  
  
    
SMARCA4 
 
  
  
    
TAL1 
 
  
  
    
TEAD4 
 
  
3 49843723 38626 rs3819325 1b 
  
CAC-bindingprotein 
  
      
Egr 
  
      
RREB1 
  
      
SP1 
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SP4 
  
      
Zfp281 
  
      
Zfp740 
  
      
ZNF219 
  
      
ZNF515 
  
      
ZNF740 
  
    
CHD2 
 
  
  
    
ETS1 
 
  
  
    
MYC 
 
  
3 49842881 39468 rs11400401 2b 
  
mTERF 
  
      
RREB-1 
  
    
SMARCA4 
 
  
  
    
ETS1 
 
  
  
    
MYC 
 
  
  
    
POLR2A 
 
  
  
    
RAD21 
 
  
  
    
GABPA 
 
  
3 49841310 41039 rs78926068 3a 
  
NFKB1 
3 49840843 41506 rs115355405 3a 
  
Meis1 
  
      
Mrg2 
  
      
Pknox1 
  
      
MEIS2 
  
      
Tgif2 
3 49840525 41824 rs201878414 2b 
  
NFKB1 
3 49924328 41979 rs7615240 2b 
  
AIRE 
  
    
POLR2A 
 
  
3 49834571 47778 rs6809879 1f 
 
RHOA   
3 49832788 49561 rs73079003 3a 
  
KLF16 
  
      
Klf7 
  
      
Sp1 
  
      
SP3 
  
    
HNF4A 
 
  
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 100 kb 
    
  
3 49829653 52696 rs7637711 1f 
 
NICN1   
  
     
RHOA   
3 49828863 53486 rs145439991 3a 
  
Egr1 
  
    
JUND 
 
  
3 49936102 53753 rs2230590 2b MYC 
 
  
3 49936715 54366 rs41291716 2b 
  
ESRRA 
  
      
ESRRG 
  
      
EWSR1-FLI1 
  
      
RARA 
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RARB 
  
      
RARG 
  
    
BHLHE40 
 
  
  
    
CTCF 
 
  
  
    
RAD21 
 
  
3 49827791 54558 rs55750059 2b 
  
Six-1 
  
      
Six-6 
3 49938758 56409 rs7616171 2b POLR2A 
 
  
3 49823200 59149 rs60844685 3a E2F1 
 
  
  
    
GATA1 
 
  
  
    
MAX 
 
  
  
    
SPI1 
 
  
3 49943570 61221 rs75195683 2b 
  
Egr 
  
      
KROX 
3 49945996 63647 rs58025924 2b 
  
LRF 
  
      
Plagl1 
  
      
ZIC1 
  
      
ZIC3 
  
      
ZIC4 
  
    
GATA1 
 
  
  
    
MAZ 
 
  
3 49818555 63794 rs9814765 2c CEBPB 
 
  
3 49817450 64899 rs9829155 1f 
 
RHOA   
3 49948627 66278 rs201449228 2b 
  
Evi-1 
  
    
GATA1 
 
  
  
    
GATA2 
 
  
  
    
POU5F1 
 
  
  
    
RBBP5 
 
  
3 49813258 69091 rs9853352 1f 
 
RHOA   
  
     
USP4   
  
     
WDR6   
3 49808981 73368 rs11717463 3a 
  
FOXP1 
  
    
MEF2A 
 
  
  
    
RUNX3 
 
  
3 49977786 95437 rs116486986 2b 
  
RNF96 
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 150 kb 
    
  
3 49771990 110359 rs9849038 1f 
 
RHOA   
3 49997963 115614 rs2624843 3a GATA1 
 
  
3 49998282 115933 rs2883057 3a GATA1 
 
  
3 49761613 120736 rs3811695 1f 
 
(dsQTL)   
3 50004209 121860 rs2252833 1d 
 
RBM6   
  
    
FOS 
 
  
 74 
  
    
RFX3 
 
  
3 49760477 121872 rs11547261 2b 
  
CREB5 
  
      
JDP2 
  
      
Pax-3 
  
    
POLR2A 
 
  
3 49760431 121918 rs34345884 2b 
  
NRSF 
  
      
REST 
  
    
POLR2A 
 
  
3 49758764 123585 rs4768 2b 
  
YY1 
  
    
MTA3 
 
  
  
    
POLR2A 
 
  
3 49758497 123852 rs34127462 3a 
  
Bcl6b 
  
    
POLR2A 
 
  
  
    
MTA3 
 
  
3 49758111 124238 rs7634945 2b 
  
ER 
  
      
ESR1 
  
    
POLR2A 
 
  
3 49756212 126137 rs35201844 2b 
  
Ascl2 
  
      
E2A 
  
    
POLR2A 
 
  
3 49755676 126673 rs62640368 2b 
  
CACCC-bindingfactor 
  
    
POLR2A 
 
  
3 49754970 127379 rs7628207 1f 
 
RHOA   
  
    
POLR2A 
 
  
3 49753901 128448 rs61743872 3a 
  
CAC-bindingprotein 
  
    
POLR2A 
 
  
3 49753788 128561 rs11720705 1f 
 
RHOA   
  
    
POLR2A 
 
  
3 49753003 129346 rs34614773 3a 
  
ZIC3 
  
      
ZIC4 
  
    
POLR2A 
 
  
3 49751856 130493 rs12715437 1f 
 
RHOA   
3 49751585 130764 rs2291542 1f 
 
WDR6   
3 49750261 132088 rs77208503 2b SPI1 
 
  
3 49745235 137114 rs11709734 1f 
 
RHOA   
3 49742107 140242 rs34154145 2b POLR2A 
 
  
3 49737323 145026 rs11130217 1f 
 
RHOA   
3 50028246 145897 rs2248256 3a 
  
TP53 
  
      
TP63 
  
      
TP73 
  
    
YY1 
 
  
3 49736269 146080 rs79587292 3a GATA1 
 
  
3 49735746 146603 rs11130214 1f 
  
SPDEF 
 75 
            WDR6   
 
The coordinate of the lead SNP (rsID rs2247036) is 49,882,349. Coordinates are 1-based. Chr stands for 
chromosome. 
 
 
Table 10. Putative Regulatory Elements Organized by Distance of the Element’s Modifying Variant 
from Lead SNP on Chromosome 15. 
 
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 10 kb 
    
  
15 73598607 1363 rs531019 2b 
  
FOXfactors 
  
      
HNF3 
15 73605644 5674 rs11630633 3a 
  
FOXP1 
  
    
BACH1 
 
  
  
    
MAFF 
 
  
  
    
MAFK 
 
  
15 73590153 9817 rs74022931 3a 
  
Nkx2-5 
  
    
IKZF1 
 
  
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 50 kb 
    
  
15 73588382 11588 rs576813 2b 
  
LRF 
  
    
CEBPB 
 
  
  
    
FOS 
 
  
  
    
MAX 
 
  
  
    
MYC 
 
  
15 73586577 13393 rs148534572 3a HNF4A 
 
  
15 73586515 13455 rs62015483 3a 
  
RFX1(EF-C) 
  
      
RFX2 
  
      
RFX3 
  
      
RFX4 
  
    
HNF4A 
 
  
15 73586267 13703 rs2252725 3a 
  
Zbtb3 
  
    
EP300 
 
  
  
    
FOXA1 
 
  
  
    
FOXA2 
 
  
  
    
HDAC2 
 
  
  
    
HNF4A 
 
  
  
    
HNF4G 
 
  
  
    
JUND 
 
  
  
    
SP1 
 
  
15 73586171 13799 rs41415044 2b 
  
Mtf1 
  
      
NF-AT 
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HDAC2 
 
  
  
    
HNF4A 
 
  
  
    
SP1 
 
  
  
    
HNF4A 
 
  
  
    
EP300 
 
  
  
    
HDAC2 
 
  
  
    
SP1 
 
  
15 73619997 20027 rs494493 2b 
  
RARB 
  
    
IKZF1 
 
  
15 73576507 23463 rs115719976 2b 
  
Evi-1 
  
      
Srf 
  
    
CTCF 
 
  
  
    
RAD21 
 
  
15 73623689 23719 rs572112 3a IKZF1 
 
  
15 73623691 23721 rs2680333 3a IKZF1 
 
  
15 73624849 24879 rs76789737 2b 
  
p53 
  
      
TP53 
  
    
IKZF1 
 
  
15 73632376 32406 rs4776632 3a 
  
Bcl6b 
  
    
CTCF 
 
  
15 73565650 34320 rs8027588 2b 
  
PRDM1 
  
      
STAT1 
  
    
CTCF 
 
  
15 73557903 42067 rs2660825 2b 
  
MRF-2 
  
    
CTCF 
 
  
  
    
CTCF 
 
  
  
    
MYC 
 
  
  
    
MYC 
 
  
  
    
NFATC1 
 
  
  
    
SIN3A 
 
  
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 100 kb 
    
  
15 73532372 67598 rs1714530 3a 
  
Elk-1 
  
    
CTCF 
 
  
  
    
RAD21 
 
  
15 73530599 69371 rs192120450 2b 
  
IRF1 
  
      
Isgf3g 
  
    
BACH1 
 
  
  
    
EP300 
 
  
15 73530356 69614 rs147551053 2b 
  
NRSE 
  
    
BACH1 
 
  
  
    
EP300 
 
  
  
    
GATA2 
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GATA3 
 
  
15 73524629 75341 rs2046017 3a 
  
FOXJ3 
  
    
MAFK 
 
  
15 73513993 85977 rs118016492 3a 
  
UF1H3BETA 
  
    
POLR2A 
 
  
15 73513938 86032 rs12373012 3a POLR2A 
 
  
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 150 kb 
    
  
15 73472104 127866 rs139043297 3b 
  
TEF 
  
    
AR 
 
  
15 73472096 127874 rs74025262 3b 
  
AR 
  
    
AR 
 
  
15 73466694 133276 rs11636981 3a 
  
TBX15 
          NFKB1     
 
The coordinate of the lead SNP (rs192656182) is 73,599,970. Coordinates are 1-based. Chr stands for 
chromosome. 
 
Table 11. Putative Regulatory Elements Organized by Distance of the Element’s Modifying Variant 
from Lead SNP on Chromosome 4 (at 111.7 Mb). 
 
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 10 kb 
    
  
4 111719978 1019 rs17042198 3a FOXP2 
 
  
4 111714889 6108 rs2220427 2b GATA6 
 
  
  
    
HNF4A 
 
  
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 50 kb 
    
  
4 111708438 12559 rs7434417 3a CEBPB 
 
  
  
    
FOS 
 
  
  
      
BARX1 
4 111677661 43336 rs74843677 3a CTCF 
 
  
  
    
RAD21 
 
  
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 100 kb 
    
  
4 111663478 57519 rs7439625 3a FOS 
 
  
4 111656967 64030 rs11944778 3a 
  
ONECUT1 
  
      
ONECUT3 
  
      
Oct-1 
  
      
FOXP1 
          ZNF263     
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The coordinate of the lead SNP (rs2129979) is 111,720,997. Coordinates are 1-based. Chr stands for 
chromosome. 
 
Table 12. Putative Regulatory Elements Organized by Distance of the Element’s Modifying Variant 
from Lead SNP on Chromosome 4 (at 112.7 Mb). 
 
Chr Coordinate Distance (bp): rsID Score Protein eQTL Motif 
  
 
within 10 kb 
    
  
4 112769004 8410 rs385040 3a CTCF 
 
  
  
    
RAD21 
 
  
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 100 kb 
    
  
4 112843090 65676 rs72899903 3a FOS 
 
  
4 112845202 67788 rs76743823 2b 
  
Foxl1 
  
      
FOXJ2 
  
      
FOXJ3 
  
    
CTCF 
 
  
  
    
FOS 
 
  
4 112846378 68964 rs17589101 3a 
  
REST 
  
    
CTCF 
 
  
4 112858746 81332 rs7670652 2b 
  
Dobox4 
  
      
Evi-1 
4 112865123 87709 rs72899924 2b 
  
GCM 
4 112873874 96460 rs115874059 3a 
  
FOXO3A 
  
    
POLR2A 
 
  
4 112876056 98642 rs75690152 3a 
  
FOXJ2 
  
    
CEBPB 
 
  
Chr Coordinate Distance (bp):  rsID Score Protein eQTL Motif 
  
 
within 150 kb 
    
  
4 112881725 104311 rs886567 3a 
  
NGFI-C 
  
      
Egr-2 
  
      
EGR1 
  
      
Zif268 
  
    
GATA3 
 
  
  
    
POLR2A 
 
  
  
    
TFAP2A 
 
  
  
    
GATA1 
 
  
  
    
SMARCA4   
4 112883200 105786 rs757507 3a EP300 
 
  
  
    
FOS 
 
  
              Bsx 
 
The coordinate of the lead SNP (rs17044095) is 112,777,414. Coordinates are 1-based. Chr stands for 
chromosome. 
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Figure 7. Quantile-Quantile Plot of P-values from Genome-Wide Association Study.  
 
The solid red line symbolizes the expected p-values on a logarithmic scale under the null hypothesis. Blue 
dots represent observed values. The dashed red lines represent the 95% confidence envelope, assuming 
that the test results are independent. 
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Table 13. Quality Statistics for Index SNPs. 
 
rsID Average r2 Minimum r2 Allele Frequency 
rs2129979 0.9859 0.9460 0.7039 
rs192656182 0.7418 0.5297 0.0087 
rs137882920 0.7190 0.6744 0.0171 
rs2247036 0.9817 0.9682 0.4722 
rs17044095 0.9964 0.9926 0.7699 
rs117367662 0.7460 0.6936 0.0594 
rs1650337 0.6620 0.5364 0.0002 
rs75972139 0.9550 0.9371 0.9840 
rs6445791 0.8707 0.8579 0.1666 
 
Shown is information for the most-associated SNPs in each associated region for all 23andMe 
participants of European ancestry. All SNPs were imputed. Average r2 is a measure of imputation quality, 
and minimum r2 is a measure of consistency of imputation quality. 
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Figure 8. Regional Association Plot for rs137882920. 
Association test results are shown as a distribution of position on chromosome 20 in the vicinity of the 
SNP along the X-axis versus negative transformed −log10 of association test P-values along the left Y-
axis. The symbol “+” indicates a genotyped SNP; “o” indicates an imputed SNP. The colors indicate the 
strength of linkage disequilibrium (LD) with the index SNP. Blue lines indicate the recombination rate 
plotted along the right Y-axis, as a function of genomic position along the X-axis. Genes in the vicinity of 
the lead SNP are shown along the X-axis.  
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 Figure 9. Regional Association Plot for rs117367662. 
Association test results are shown as a distribution of position on chromosome 11 in the vicinity of the 
SNP along the X-axis versus negative transformed −log10 of association test P-values along the left Y-
axis. The symbol “+” indicates a genotyped SNP; “o” indicates an imputed SNP. The colors indicate the 
strength of linkage disequilibrium (LD) with the index SNP. Blue lines indicate the recombination rate 
plotted along the right Y-axis, as a function of genomic position along the X-axis. Genes in the vicinity of 
the lead SNP are shown along the X-axis.  
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 Figure 10. Regional Association Plot for rs1650337. 
Association test results are shown as a distribution of position on chromosome 12 in the vicinity of the 
SNP along the X-axis versus negative transformed −log10 of association test P-values along the left Y-
axis. The symbol “+” indicates a genotyped SNP; “o” indicates an imputed SNP. The colors indicate the 
strength of linkage disequilibrium (LD) with the index SNP. Blue lines indicate the recombination rate 
plotted along the right Y-axis, as a function of genomic position along the X-axis. Genes in the vicinity of 
the lead SNP are shown along the X-axis.  
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 Figure 11. Regional Association Plot for rs75972139. 
Association test results are shown as a distribution of position on chromosome 1 in the vicinity of the 
SNP along the X-axis versus negative transformed −log10 of association test P-values along the left Y-
axis. The symbol “+” indicates a genotyped SNP; “o” indicates an imputed SNP. The colors indicate the 
strength of linkage disequilibrium (LD) with the index SNP. Blue lines indicate the recombination rate 
plotted along the right Y-axis, as a function of genomic position along the X-axis. Genes in the vicinity of 
the lead SNP are shown along the X-axis. 
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 Figure 12. Regional Association Plot for rs6445791. 
Association test results are shown as a distribution of position on chromosome 3 in the vicinity of the 
SNP along the X-axis versus negative transformed −log10 of association test P-values along the left Y-
axis. The symbol “+” indicates a genotyped SNP; “o” indicates an imputed SNP. The colors indicate the 
strength of linkage disequilibrium (LD) with the index SNP. Blue lines indicate the recombination rate 
plotted along the right Y-axis, as a function of genomic position along the X-axis. Genes in the vicinity of 
the lead SNP are shown along the X-axis.  
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